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ABSTRACT 
 
Poor Maternal nutrition has been implicated to reduce nutrient transport to the conceptus. 
Therefore, we hypothesized that maternal nutrition and day of gestation would impact mRNA 
expression of nutrient transporters GLUT1, GLUT3, GLUT5, GLUT14, CAT-1, CAT-2, and CAT-
3 in beef heifers. Crossbred Angus heifers (n = 49) were bred via AI, assigned to nutritional 
treatment (CON = 100% of requirements for 0.45 kg/d gain and RES = 60% of CON) and 
ovariohysterectomized on d 16, 34, or 50 of gestation. Expression of CAT-2 was the only gene in 
any tissue to demonstrate a day × treatment interaction. Expression of nutrient transporters were 
not influence by nutritional treatment (P > 0.05); however, transporters were differentially 
expressed by day of gestation (P ≤ 0.05). We interpret these results to indicate that day, has a 
greater influence than a 40% global nutrient restriction on mRNA expression of nutrient 
transporters in bovine utero-placental tissues. 
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CHAPTER 1: LITERATURE REVIEW 
 
Establishment of Pregnancy 
The use of artificial reproductive technologies (ART) such as artificial insemination (AI), 
estrous synchronization, and fixed-time AI are some of the most effective tools available to cattle 
producers to improve productivity and profitability of their cattle operation (Cothren, 2012; 
Dahlen et al., 2014). Benefits associated with using AI are: the ability to use sires of superior 
genetic merit, improved production traits in offspring, the ability to mate specific sires to 
individual cows, reducing the number of herd bulls needed in a single operation, increased 
genetics for replacement heifers, reducing spread of diseases throughout a herd, higher growth 
performance and calf value, and if combined with estrous synchronization protocols, can create a 
shorter calving season with a more consistent and uniform calf crop (Cothren, 2012; Comerford, 
2013). Although there are proven benefits for the utilization of ART, less than 10% of US-based 
operations utilize them (Dahlen, 2010; Cothren, 2012; Comerford, 2013).  
Fertilization rates for first service AI are approximately 90% in beef heifers (Bridges et 
al., 2013); however, by d 30 of gestation, only 50 to 60% of heifers maintain a viable pregnancy. 
Moreover, Thatcher et al., (1994) indicated that up to 80% of all embryonic loss occurs before d 
40 of gestation in sheep and cattle. Across all livestock species, as well as humans, it is estimated 
that 2/3 of all embryonic losses occur during the peri-implantation/peri-attachment period of 
gestation (Bazer and First, 1983; Nancarrow, 1994). The main cause of this is failed 
implantation/attachment (humans or ruminants, respectively) of the chorioallantois to the uterine 
endometrium, which accounts for 50 to 75 % of failures to establish pregnancy (Bazer et al., 
2011a). 
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Multiple events must take place (Figure 1.1) during the first 50 days of gestation for a 
successful pregnancy to be established and maintained, beginning with ovulation from the ovary 
and successful fertilization of the ovum by the sperm within the oviduct to form a zygote. The 
zygote will undergo multiple cleavage events in order to form into a morula (32 to 64 cell 
embryo) by days 4 to 7 after fertilization (Senger, 2012). During these cleavage events, the 
developing morula will move from the site of fertilization in the oviduct, and migrate to the 
uterus. The second stage of development is compaction, in which the cells of the morula 
continue to grow and divide forming two distinct cell layers of a blastocyst called the inner cell 
mass (ICM) and the trophoblast (formed 7 to 12 days after fertilization; Senger, 2012). Sodium 
is pumped into the blastocyst by the outer cells of the morula which causes fluid to accumulate 
within the blastocyst forming the blastocoele. The blastocyst therefore consists of an ICM as 
well as the fluid filled blastocoele surrounded by a single layer of cells called the trophoblast. 
The inner cell mass is what will give rise to the embryo/fetus, and the trophectoderm will give 
rise to the placenta (Rowson and Moor, 1966; Bindon, 1971; Wintenberger-Torres and Flechon, 
1974; Barcroft et al., 1998; Senger, 2012). Fluid continues to build up within the blastocyst, cells 
continue to divide and grow, and pressure builds up within the blastocyst until, with the aid of 
proteolytic enzymes, the zona pellucida cracks, and the blastocyst “hatches”. The hatching of the 
blastocyst takes place around days 9 to 11 after fertilization (Senger, 2012), yielding a free 
blastocyst which is floating in the uterus. During this time point, the blastocyst begins to 
transition from its spherical form, and elongate into a large spherical, tubular, and filamentous 
conceptus consisting of the embryo and the extra embryonic membranes. At d 13 of gestation, 
the bovine blastocyst is roughly 3 mm in diameter, but by day 17, the blastocyst will become 
approximately 250 mm in length. This step of elongation of the conceptus is very important for 
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the subsequent attachment steps as well as maternal recognition of pregnancy. As the conceptus 
elongates, it orients itself within the uterine lumen, and begins to adhere to the uterine 
endometrium. It is at this time, that the mononucleated trophectoderm (formerly described as 
trophoblast) of the conceptus begins to release interferon-τ (IFN-τ; 16 to 17 days post-
fertilization; Senger, 2012), which is the maternal recognition of pregnancy signal in ruminants. 
Successful release of IFN-τ from the conceptus silences expression of genes involved in the 
pulsatile release of prostaglandin (PGF2α), which would terminate the pregnancy, by causing 
regression of the corpus luteum (CL) and termination of production of progesterone at sufficient 
levels to maintain pregnancy (Bazer et al., 1997; Bazer, 2013; Bazer et al., 2015). The 
developing placenta has been forming during this time from the extraembryonic membranes of 
the pre-attached embryo. This development is an obligatory step in the acquisition of the 
embryo’s ability to attach to the uterus. As the hatched blastocyst begins to grow and expand, a 
layer just beneath the ICM called the mesoderm and endoderm, begins to grow. The endoderm 
grows downward lining the trophoblast forming the first membrane called the yolk sac. The 
mesoderm continues to grow and expand forming a sac that surrounds the yolk sac and pushes 
against the trophectoderm forming a double membrane called the chorion. The chorion then 
expands surrounding the embryo forming the amniotic sac. The allantois is the final membrane 
compartment which originates form the primitive gut of the embryo. This membrane collects 
liquid waste from the embryo. As the embryo continues to grow, the allantois grows in size as 
well eventually fusing with the chorion forming the chorioallantois, which will grow and develop 
into the placenta (Bryden et al., 1972; Mossman, 1987). By days 18-22 the conceptus would 
have successfully adhered to the uterine endometrium, and by day 30, complete attachment of 
the chorioallantois to the endometrium would have taken place. 
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Figure 1.1. Embryonic development and uterine adaptations A) Oocytes fertilized in the 
oviduct enter the uterus at the morula stage and advance developmentally after hatching from 
the zona pellucida to spherical blastocysts that then transition to the large spherical, tubular, 
and filamentous conceptus (the embryo and its extraembryonic membranes) with IFN-τ, the 
pregnancy recognition signal secreted from mononuclear trophectoderm cells between Days 
10 and 21 of pregnancy. B) Endometrial epithelia cease expressing receptors for progesterone 
(PGR) due to autoregulation by progesterone, while IFN-τ silences expression of receptors for 
estradiol-17 β (ESR1) and oxytocin receptor (OXTR) to abrogate development of the 
mechanism for oxytocin-mediated pulsatile release of Prostaglandin F (PGF2α), which would 
otherwise cause regression of the corpus luteum and cessation of their secretion of 
progesterone. Endometrial stromal fibroblasts express PGR and secrete progestamedins, 
particularly fibroblast growth factor-10 (FGF10), that regulate uterine epithelium cell 
function. With down-regulation of PGR in uterine epithelia, uterine luminal epithelium (LE) 
and superficial glandular epithelium (sGE) express genes that are either induced by 
progesterone (P4) or induced by P4 and further stimulated by IFN-τ. Furthermore, IFN-τ 
induces expression of interferon regulatory factor-2 (IRF2) in uterine LE and sGE to silence 
expression of classical IFN-stimulated genes and allows expression of a unique set of genes 
that promotes conceptus growth and development. Endometrial GE cells and stromal 
fibroblasts do not express IRF2 and, therefore, express classical IFN-stimulated proteins. 
Collectively, molecules secreted by uterine epithelia or transported into the uterine lumen by 
uterine epithelia form histotroph required for conceptus development. C) The ovine conceptus 
undergoes the adhesion cascade for implantation. Taken with permission from Soc. Study 
Reprod., Bazer et al., 2011. 
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.           After d 30 of gestation, the chorioallantois begins to differentiate between the 
cotyledonary tissue of the placenta, and the intercotyledonary tissue. The cotyledons arise due to 
increased local force of blood pressure from the endometrium on specific points of the placenta. 
This causes structural changes in the placenta involving a three step process: 1) cavitation, 2) 
crowning and extension of anchoring villi, and 3) completion by development of the supplying 
vascular pattern (Reynolds, 1966). These cotyledons will form the point of attachment between 
the caruncles on the uterine endometrium and the placenta, allowing for exchange of nutrients 
through hemotrophic nutrition, and will continue to grow and develop throughout gestation.  
Throughout the first 50 day timeframe, the embryo is growing rapidly. By approximately 
day 45, organogenesis (development of the fetal organs) would be completed for some organs; 
however, although differentiated, organ systems like the gastrointestinal system (Noah et al., 
2011) or lungs are not completely developed and functional. This indicates, that during the first 
50 days of gestation, all of the fetal organ systems would be growing, developing, and 
differentiating from one another (Winters et al., 1942), growing in size after d 50 as well as 
further developing and differentiating, following the steps of 1) morphogenesis and cell 
proliferation, 2) cell differentiation, and 3) functional maturation (Colony, 1983).  
 
Histotroph and mTOR 
In the early 20th century, the terms hemotroph and histotroph were coined to describe 
those substances essential for support of conceptus and fetal development supplied via the uterus 
either: (1) directly from blood (hemotroph); or (2) from the uterine endometrium (histotroph) 
(Bazer, 1975; Filant and Spencer, 2014). Because hemotrophic nutrition has yet to be established 
during the first 50 days of gestation, a proper uterine milieu (histotroph) must be present in order 
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to supply the developing embryo with the necessary nutrients to support the growth and 
differentiation of tissues (Bazer, 2011a). Histotroph includes nutrient transport proteins, ions, 
mitogens, cytokines, lymphokines, enzymes, hormones, growth factors, proteases and protease 
inhibitors, amino acids, glucose, fructose, vitamins and other substances (Bazer, 1975; Bazer et 
al., 2011a; Spencer and Bazer, 2004; Bazer et al., 2011b). In ruminants, histotroph is essential to 
the development of the conceptus throughout pregnancy (Bazer et al., 2011a). Histotroph, also 
called uterine milk (Bonnet, 1882), is secreted from glands within the uterine endometrium 
(Bazer, 1975; Gray et al., 2001; Spencer et al., 2008). The uterine endometrium of cattle consists 
of multiple aglandular caruncular areas, which are dense stromal areas covered by a simple 
luminal epithelium (LE), as well as intercaruncular areas (Filant and Spencer, 2014).  The 
intercaruncular areas of the endometrium contain many hundreds of glands in a cross-section of 
the uterine wall (Filant and Spencer, 2014). These glands begin to develop as invaginations of 
LE that progressively invade the stroma, resulting in an extensive network of epithelial glands 
(Filant and Spencer, 2014). If these glands were to not develop, the conceptus would not be able 
to elongate, IFN-τ would not be produced, and PGF2α would lyse the CL, and pregnancy would 
be terminated. This was established with the uterine gland knockout model in sheep (Bartol et 
al., 1988a; Bartol et al., 1988b). Knockdown of uterine glands in sheep resulted in infertility, 
although blastocysts were normal on d 9 after fertilization, conceptuses were severely growth-
retarded by d 12 or 14 (Filant and Spencer, 2014). This lack of elongation emanated from the 
absence of histotrophic secretions into the uterine lumen from the GE (Gray et al., 2001a; Gray 
et al., 2002).  
Some of the essential constituents of histotroph, which are the main focus of the 
remainder of this thesis, are glucose, fructose, and cationic amino acids. These components of 
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histotroph act on a nutrient sensing pathway called the mammalian target of rapamycin (mTOR). 
The mammalian target of rapamycin is a serine/threonine protein kinase that regulates a variety 
of anabolic and catabolic processes in response to nutrients, growth factors, hormones, as well as 
some stresses (Chantranupong et al., 2016; Tan and Miyamoto 2016; Wang et al., 2016b). The 
mammalian target of rapamycin is the mammalian homologue of TOR which was cultured in 
yeast cells. Rapamycin is a potent antifungal macrolide originally isolated form the soil of Rapa 
Nui (Easter Island; Vazina et al., 1975). Rapamycin is responsible for anti-proliferative and 
immunosuppressive activities in both prokaryotes and eukaryotes. The mammalian target of 
rapamycin is the direct target of rapamycin, and is responsible for regulation of protein, lipid, 
and nucleotide synthesis, ribosome and lysosome biosynthesis, expression of metabolism-
regulated genes, autophagy and cytoskeletal reorganization (Wang et al., 2016b). The 
mammalian target of rapamycin is made up of two complexes, mTORC1 (proliferation) and 
mTORC2 (cytoskeletal reorganization, migration and adhesion) with both aiding in the same 
task of conceptus elongation and attachment for implantation (Wang et al., 2016b).   
 The mammalian target of rapamycin is a nutrient sensing pathway and behaves 
differently under nutrient rich and nutrient poor conditions. Under nutrient rich conditions, 
mTORC1 and mTORC2 support cellular growth, cytoskeletal remodeling, and suppresses 
autophagy. Under nutrient starved conditions, mTORC1 is inhibited and autophagy is induced to 
provide an energy source for the cell (Tan and Miyamoto, 2016). Therefore, it is understandable 
that the lysosome is a critical organelle for mTORC1 activation, and amino acids promote the 
translocation of mTORC1 to its surface where it is to be activated.  
The mTORC1 complex consists of mTOR, Regulatory-associated protein of mTOR 
(RAPTOR), DEP domain-containing mTOR-interacting protein (DEPTOR), proline rich Akt 
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substrate 40 kDa (PRAS40), mammalian lethal SEC13 protein 8 (MLST8) as well as upstream 
and downstream kinases responsible for either inducing or suppressing mTOR or autophagy at 
the lysosome (Tan and Miyamoto, 2016; Wang et al., 2016b). The kinase activator Rheb, resides 
on the lysosome surface. Additionally, bound to the membrane are the Ragulator, Rag GTPases 
which are composed of four members which form heterodimers RagA/B, and RagC/D 
(Chantranupong et al., 2016; Tan and Miyamoto 2016). These Rag complexes mediate the 
mTORC1 translocation to the lysosome in response to amino acid stimulation (Sancak et al., 
2010).  
The mTORC2 complex consists of mTOR, rapamycin-insensitive companion of mTOR 
(RICTOR), mammalian stress-activated MAP kinase interaction protein 1 (MSIN1), MLST8, 
DEPTOR, and protein observed with RICTOR (PROTOR) (Loewith et al., 2002; Pearce et al., 
2007; Laplante and Sabatini, 2009; Wang et al., 2016).  
 
Arginine Activation of mTORC1 and mTORC2 
 In the presence of amino acids, mTOR translocates to the lysosome in which it binds the 
the Ragulator/Rag complex as previously stated. Rheb, a direct activator of mTORC1 is located 
on the lysosomal membrane, and once mTOR is in close proximity to Rheb, allows activation of 
mTOR. Thus, the docking of mTOR to the lysosome, allows for the necessary proximity of the 
mTOR/Rheb associated complex to inhibit autophagy related signals. When amino acids become 
scarce, mTORC1 is removed from the Ragulator/Rag complex, loses its proximity with Rheb, 
and becomes inactive. Once inactivated, TFEB (transcription factor EB) becomes bound to the 
lysosome and induces autophagy in the cell (Tan and Miyamoto, 2016).  
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Figure 1.2. Model for induction of cell signaling for proliferation, migration, adhesion, and 
cytoskeletal remodeling of conceptuses via mTORC1 and mTORC2 signaling cascade. AKT1, 
proto-oncogenic protein kinase 1; FAK, focal adhesion kinase; PDK1, 
phosphoinositidedependent protein kinase 1; mTOR, mammalian target of rapamycin; 
RAPTOR, regulatoryassociated protein of mTOR; RICTOR, rapamycin-insensitive companion 
of mTOR; IGF2, insulin-like growth factor 2; type I IGF2, type I insulin-like growth factor 
receptor; ILK, integrin-linked kinases; IRS1, insulin receptor substrate 1; PKC, protein kinase 
C; SGK, serum/glucocorticoid-regulated kinase; MLST8, mammalian lethal with SEC13 
protein 8; PRAS40, proline-rich Akt/PKB substrate 40 kDa; DEPTOR, DEP domain-
containing mTORinteracting protein; MSIN1, mammalian stressactivated MAP kinase 
interacting protein 1; PROTOR, protein observed with RICTOR; NCK2, noncatalytic region of 
tyrosine kinase, beta; NO, nitric oxide; NOS3, nitric oxide synthase 3; ODC1, ornithine 
decarboxylase; PI3K, phosphatidylinositol 3-kinase; LIMS1, LIM and senescent cell antigen-
like domains 1; S6K, S6 kinase; SPP1, secreted phosphoprotein 1. Taken with permission from 
Elsevier, from Wang et al., 2016b. 
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Specific arginine activation of mTORC1 complex comes through its interaction with 
another protein, Secreted Phosphoprotein 1 (SPP1; Wang et al., 2016b). Secreted Phosphoprotein 
1 is responsible for regulation of cell proliferation, migration, adhesion, differentiation, survival, 
and immune factors, as well as its actions in adhesion of the trophectoderm to the uterine luminal 
epithelium during implantation (Wang et al., 2016b). However, SPP1 alone does not cause 
implantation and adhesion. Physiological concentrations of arginine acting in coordination with 
SPP1 signal the mTOR, PI3K, and MPK3 pathways to signal cell migration and proliferation. 
Arginine is metabolized to ornithine and subsequently to polyamines, or to nitric oxide (NO) 
which all activate mTOR through interacting mTOR with Rheb (Wang et al., 2016b). Once 
activated, mTOR acts on downstream effectors by phosphorylating them, and regulating cell 
proliferation.   
Arginine and SPP1, together work to activate mTORC2 as well. This is the driving force 
behind the elongation of the blastocysts, causing the cellular reorganization and change from a 
spherical blastocyst, to the long filamentous tubule which will secrete IFN-τ and implant on the 
uterine epithelium (Wang et al., 2016a). 
 
Glucose and Fructose Activation of mTORC1  
Within particular cell types, glucose and fructose stimulate mTORC1 differently. In 
cardiac cells, the enzyme hexokinase which catalyzes the phosphorylation of glucose to glucose-
6-phosphate, activates mTORC1 through its binding with Raptor. In the absence of glucose, 
AMPK, inactivates mTORC1 yielding increased autophagy (Tan and Miyamoto, 2016). In 
allantoic and amniotic fluids during early gestation; however, fructose is the main hexose in fetal 
fluids, not glucose (Kim et al., 2012). This is because the placenta metabolizes glucose-6-
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phosphate to fructose-6-phosphate, making fructose more abundant in allantoic fluid (Wang et 
al., 2016). Once inside the cell, glutamine-fructo-phosphate transamidase-1 (GFPT-1) catalyzes 
the change from fructose-6-phsophate to GlcN-6-P. In this mechanism, glutamine is deaminated 
to glutamate, which will be converted to α-keto-glutarate, also stimulating mTOR, connecting 
glucose and fructose metabolism to glutamine activation of mTOR (Wang et al., 2016). Thus, 
UDP-GlcNAc, directly stimulates Akt (the proline rich substrate) which activates mTOR. Once 
activated, mTOR phosphorylates downstream effectors in a similar mechanism compared with 
arginine activation of mTOR. 
 
  
Figure 1.3. Schematic diagram of the GFPT1-OGT-mediated Akt-TSC2-mTOR signaling 
cascade affected by glucose and fructose in oTr1 cells. Fructose stimulates GFPT1 for 
hexosamine biosynthesis to provide UDP-GlcNAc for O-GlcNAcylation, thereby activating Akt-
TSC2-mTOR signaling cascade for stimulation of oTr1 cell proliferation and growth. Akt, proto-
oncogenic protein kinase Akt; TSC2, tuberous sclerosis 2; mTOR, mechanistic target of 
rapamycin; RPS6, ribosomal protein S6; RPS6K, ribosomal protein S6K; EIF4EBP1, eukaryotic 
translation initiation factor 4E-binding protein 1; GlcN-6-P, glucosamine-6- phosphate; GFPT1, 
glutamine-fructose-6-phosphate transaminase 1; OGT, O-linked N-acetylglucosamine 
transferase; OGA, O-GlcNAcase; UDP-GlcNAc, UDP-N-acetylglucosamine. Taken with 
permission from Elsevier, Wang et al., 2016b. 
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mTOR Downstream Effectors 
 The mammalian target of rapamycin’s downstream effectors to protein synthesis and 
cellular proliferation are Ribosomal Protein S6K (RPS6K), Ribosomal Protein S6 (RPS6), and 
Eukaryotic Translation Initiation Factor 4E-Binding Protein (EIF-4EBP1). Both types of 
downstream effectors work in different ways and are stimulated differently by mTOR to increase 
proliferation of cells. 4E-BP aids to increase mRNA translation, and S6K is responsible to 
increase ribosome biogenesis (Wang et al., 2016).  
 Initiation factor 4E-Binding Protein is a series of multiple proteins which bind to 
Eukaryotic Translation Initiation Factor 4E (eIF4E).  Eukaryotic Translation Initiation Factor 4E 
is bound by binding proteins such as 4E-BP1, which once released, allows for eIF4E to bind to 
the 5’ end of mRNA and along with helicase, unwind the mRNA in order to promote translation 
of the protein for increased proliferation. In order to do this, mTOR must phosphorylate multiple 
components of 4E-BP1 including Thr37, Thr46, Ser65, and Thr70 cooperatively in order to 
successfully dissociate 4E-BP1 from EIF4E (Hay and Sonenberg 2004).  
 The other downstream effect S6 Kinase is made of two kinase proteins S6K1 and S6K2. 
Both proteins are phosphorylated and regulate cell growth in mammals. S6K1 acts through 
increased mRNA translation, which encode specifically for components of the translation 
process, including ribosomal proteins, elongation factors, and poly (A)-binding protein. This 
action on translation is indirect and is mediated through S6K action on EIF4B in order increase 
mRNA translation and ribosome biogenesis (Hay and Sonenberg, 2004). 
 Therefore, the presence of glucose, fructose, and arginine are vital to the development of 
the conceptus, and are secreted by transporters in the glandular epithelium (GE), caruncle, 
13 
 
chorioallantois, cotyledon and amnion in order to sufficiently supply nutrients to the developing 
conceptus. 
 
Utero-placental Glucose Transporters 
There are two types of glucose transporters in the utero-placenta: 1) Facilitated diffusion 
transporters which transport glucose down their concentration gradients, known at GLUTs or 
SLC2 family, and 2) sodium-coupled glucose transporters which co-transport one molecule of 
glucose with two sodium ions, known as SGLTs or SLC5 family (Frolova and Moley, 2011). 
The main focus of this section of the review will be on sodium-independent glucose transporters 
GLUT1, GLUT3, and GLUT14 (SLC2A1, SLC2A3, and SLC2A14) and sodium-independent 
fructose transporter GLUT5 (SLC2A5). Another glucose transporter in utero-placental tissues 
that is also heavily investigated is GLUT4 (SLC2A4); however, this transporter is insulin-
dependent (Cushman and Wardzala, 1980; Suzuki and Kono, 1980); Wardzala and Jeanrenaud, 
1981; James et al., 1988) and will not be a topic of discussion for this review.  
The SLC2 protein family contains 14 currently known isoforms and each member has a 
distinct tissue-specific expression and binding affinities for individual hexose substrates 
(Augustin, 2010). These isoforms are facilitative diffusion transporters that alternate between 
two conformational states with the substrate-binding site facing extracellularly (Bell et al., 1993). 
Each transporter contains approximately 500 amino acids and a 12 membrane-spanning α-helical 
segment with intracellularly located NH2 and COOH terminal. There is only one large 
intracellular loop connecting the transmembrane segments between helices 6 and 7. 
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The remaining loops are very short, consisting of anywhere from 8 to 12 residues. The 
potential site for N-glycosylation can be found in the extracellular loop connecting 
transmembrane segments 1 and 2 (Figure 1.4). Moreover, mutation of the N-glycosylation site 
increases the Km for glucose transport by 2-fold, indicating that the glycosylation site may 
contribute to the formation of structure that is capable of high affinity transport (Asano et al., 
2001).  
In order to fully understand facilitative diffusion transporters, it is vital to understand 
transport kinetics, and how carrier mediated transport functions. All transporters investigated 
Figure 1.4. Model for the orientation of mammalian facilitative sugar transporters in the 
membrane. The 12 transmembrane helices are shows as boxes and are numbered 1-12. The 
potential site for N-glycosylation in the extracellular loop connecting transmembrane 
segments 1 and 2 is show. Invariant residues are noted using the single-letter abbreviations for 
the amino acids with polar residues located in the lipid bilayer being show in filled circles. 
The residues whose mutagenesis or deletion affects transporter function are noted in red. 
Taken with permission from J. Biol. Chem, Bell et al., 1993. 
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within are facilitative diffusion transporters. Indicating that these transporters facilitate the 
transport of molecules down their concentration gradient in order to equilibrate their 
concentration gradients and are not coupled with the translocation process of another chemical or 
vector (Busch and Saier, 2002). The transport process can be described by a four step process: 1) 
Binding- solute binds to one face of the membrane, 2) Transport- conformational change closes 
first binding site and exposes binding site on other side of the membrane, 3) Dissociation- solute 
dissociates, and 4) Recovery- empty transporter reverses to initial conformation (Figure 1.5; 
Voet and Voet, 2011). As stated previously, individual transporters operate with individual tissue 
specificities and solute affinities which is determined through their Km (Michaelis constant). This 
is determined by indicating the transporters Vmax (substrate concentrations at which the 
transporter is saturated), and dividing by 2, such that the Km is the substrate concentration at 
which the transport velocity is half-maximal. Therefore, if a transporter has a small Km value, it 
achieves maximal transport efficiency at a low substrate concentration (Voet and Voet, 2011).  
  
  
Figure 1.5. Alternating conformation model for glucose transport. Taken with permission 
from Wiley, Voet and Voet, 2011. 
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Glucose transporter GLUT1 (Solute carrier 2 member 1, SLC2A1) is ubiquitous in 
expression across all organs, and is commonly thought to be responsible for basal level of 
glucose uptake in most cell types (Frolova and Moley, 2011).  GLUT1 is found in high levels in 
all fetal tissues as well as being most abundant in fibroblasts, erythrocytes, and endothelial cells 
with low expression in muscle, liver and adipose tissue in adults (Olson and Pessin, 1996). It has 
a high affinity for glucose ranging from 3-5 mM depending on the tissue, with a uterine transport 
Km of 3 mM (Mueckler, 1994; Augustin, 2010). In uterine tissue, GLUT1 has been localized in 
the stroma, LE, and GE (Korgun et al., 2001; Gao et al., 2009; Frolova and Moley, 2011). 
During gestation, expression of GLUT1 changes dramatically. In sheep, GLUT1 expression was 
greatest on d 14 of gestation (time of maternal recognition of pregnancy in sheep; Senger, 2012), 
and greater in pregnant, compared with cyclic ewes (Gao et al., 2009). In humans and rodents, 
GLUT1 increases in abundance in stromal tissue during decidualization (differentiation in 
uterine cells in response to progesterone; Frolova and Moley, 2011). Therefore, it is of no 
surprise to see that GLUT1 expression is increased in response to progesterone and decreased in 
response to estrogen, which has been noted in human, mouse and ovine endometria (Frolova and 
Moley, 2011; Gao et al., 2009). Additionally, GLUT1 is classified as an interferon stimulated 
gene (ISG), and expression of GLUT1 is increased in response to IFN-τ in the uterine lumen. In 
sheep, expression of GLUT1 in the presence of progesterone (P4) was 4.2-fold greater than 
controls, and 2.1-fold greater than controls in the presence of IFN-τ. When P4 and IFN-τ were 
combined in the media, expression of GLUT1 increased nearly 8-fold greater than controls (Gao 
et al., 2009). This indicates that across species, GLUT1 behaves similarly, and may serve as the 
main glucose transporter for the pre-attachment embryo. In placental tissue of sheep, GLUT1 
was localized to the trophoblast and baso-lateral membranes, with none found in the microvillar 
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membrane of the developed chorioallantois (Wooding et al., 2005), and was also localized in the 
trophectoderm and extra embryonic endoderm of the developing conceptus (Gao et al., 2009). In 
humans, GLUT1 was isolated in both the microvillous and basal membranes of the placenta, 
with microvillar membrane transport being 20-fold greater than basal transport (Jansson et al., 
1993), indicating that basal glucose transport is the rate limiting step (Illsley, 2000), and that 
GLUT1 would be primarily established for transport from the histotrophic secretions into the 
lumen of the uterus (Desoye and Shafrir; 1994). 
Glucose transporter GLUT3 (Solute carrier 2 member 3, SLC2A3) has the highest known 
transport capacity of any glucose transporter at 1.5 mM, and also has the greatest turnover 
number of the GLUT isoforms ensuring efficient uptake of glucose (Thorens and Mueckler, 
2010). GLUT3 is the major neuronal glucose transporter, present in both dendrites and axons, 
and its level of expression in different regions of the brain correlates with regional cerebral 
glucose utilization (Simpson et al., 2008, Thorens and Mueckler, 2010). In mouse sperm, GLUT3 
is highly expressed and controls glucose uptake and metabolism necessary for motility and 
maturation (Thorens and Mueckler, 2010). Glucose transporter GLUT3 is unique in comparison 
with other glucose transporters in utero-placental tissues in that a mutation of the GLUT3 gene in 
mice caused early embryonic mortality, indicating that the amount of glucose being transported 
by GLUT3 simply could not be made up for by other utero-placental glucose transporters 
including GLUT1, GLUT4, or GLUT8 (Ganguly et al., 2001). In the mouse uterus, the presence 
of GLUT3 is very low during the beginning stages of gestation and increasing in presence post 
decidualization of the uterus and throughout gestation (Yamaguchi et al., 1996). Similarly, 
GLUT3 protein was reported in the uterine epithelium and stroma starting on gestational day 1 
and increasing through day 4 in the rat (Korgun et al., 2001). In sheep, GLUT3 was not localized 
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from d 10 to 20 of gestation (Gao et al., 2009), however in Holsteins, GLUT3 was isolated in 
both caruncular and intercaruncular endometrium, but was not different in expression from days 
28 to 42 of gestation (Lucy et al., 2012). GLUT3 is commonly known for being a placental 
transporter, due to the high energy demands of both the growing placenta as well as the 
developing conceptus (Simpson et al.,2008). In sheep, GLUT3 was localized to the microvillous 
membrane of the placenta, but not on the placentome. GLUT3 was exclusively localized to the 
microvillar junction, with trophoblast and uterine epithelia surfaces remaining unlabeled 
(Wooding et al., 2005). During early development of the conceptus, GLUT3 is highly expressed 
on the trophoblast cell layer indicating that during this time of cell growth and differentiation of 
the conceptus from tubular to filamentous, a scavenging of energy may be taking place to ensure 
proper growth and development (Frolova and Moley, 2011).  
The glucose transporter gene GLUT14 (solute carrier family 2 member 14, also known as 
SLC2A14), is one of the least studied transporters, and encodes a protein that is 497 amino acids 
in length, and shares 95% homology to GLUT3 (Wu and Freeze, 2002). The GLUT14 gene is 
considered a duplicon, as it may have arisen as a possible result of a duplication of GLUT3 (Wu 
and Freeze, 2002).  Contrary to GLUT3, however, GLUT14 has previously been specifically 
expressed in the testis, and was found to have expression levels four-fold greater than GLUT3 in 
testis (Wu and Freeze, 2002). No research has been found in the literature determining the 
transport capacity of GLUT14, to determine if it is comparable to GLUT3. However, like other 
GLUT transporters, GLUT14 contains 12 putative membrane-spanning helices along with sugar-
transporter signature motifs that have previously been shown to be essential for sugar transport 
activity (Wu and Freeze, 2002). This indicates that GLUT14 should be able to transport glucose, 
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and establishment of its transport capacity would more greatly determine its role in glucose 
transport. 
Fructose transporter, GLUT5 is the only GLUT protein with a high specificity for 
fructose (Douard and Ferraris, 2008). GLUT5 is most predominantly found in the apical 
membrane of the enterocyte, where it provides a major route for the absorption of dietary 
fructose (Thorens and Mueckler, 2010). In the human oocyte, GLUT5 does not exhibit glucose 
transport capabilities; however, is able to transport fructose at a Km of ~ 6mM (Burant et al., 
1992). In the bovine, high concentrations of GLUT5 are found on fast-cleaving embryos which 
are more likely to develop to the blastocyst stage due to their enhanced nucleotide synthesis 
(Gutierrez et al., 2004). Additionally, expression of GLUT5 in-vitro, was greater in the low 
oxygenated environment, compared with the high oxygenated environment (Balasubramanian et 
al., 2007), indicating that expression of GLUT5 would be greater in the pre-attachment uterine 
environment compared with 2nd or 3rd trimester of gestation in which hemotrophic nutrition has 
been established and exchange of gases is taking place. 
Normal serum glucose concentration in 2 year old beef heifers is 3.7 mM (Doornenbal et 
al., 1988). This indicates that GLUT1 and GLUT3, as well as possibly GLUT14 would be able to 
transport glucose from the maternal to the fetal system at a greater capacity than what is 
available in the maternal system. Fructose concentrations in maternal serum are low (< 1 mM) 
due to metabolism of fructose by the liver (absorbed via GLUT2), where-as glucose may pass 
through the liver and be metabolized anywhere in the body (Quezada-Calvillo et al., 2006). 
Therefore, it may be assumed that the ratio of glucose to fructose in fetal fluids (allantoic and 
amniotic) would be high; however, in early pregnancy this isn’t the case. In the uterine lumen of 
sheep, glucose concentrations increase 6-fold from d 10 to 15 of gestation (500 to 3,000 nmol, 
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respectively (Gao et al., 2009). However, in allantoic fluid, concentrations of fructose range from 
11.1 to 33.30 mM whereas glucose concentrations range from 0.55 to 1.67 mM from d 25 to 120 
in sheep (Bazer et al., 2012). This is because fructose, is more abundant sugar in fetal blood, 
being found in 3-4 times greater amounts than glucose (Bacon and Bell, 1946 and 1948; Barklay 
et al., 1949, Battaglia and Meshia, 1978; Kim et al., 2012). Several studies outlining fructose and 
glucose utilization by the fetus have determined several conclusions: 1) injection of glucose into 
ewes results in a rapid increase in glucose followed by a protracted increase in fructose in fetal 
blood; (2) injection of glucose into the umbilical vein of the fetus increases glucose in maternal 
blood and hyperfructosemia in the fetus, indicating that glucose can move from conceptus 
vasculature to maternal blood, whereas fructose derived from glucose is not transported into 
maternal blood; 3) the placenta is the site of conversion of glucose to fructose; 4) fructose is 
produced continuously by the placenta independent of glucose concentration in maternal or fetal 
blood; and 5) the flux of glucose from the maternal to the fetal circulation can be as much as 70 
mg/min in ewes made hyperglycemic (Barklay et al., 1949; Huggett et al., 1951; Alexander et 
al., 1955a; Alexander et al. 1955b; Kim et al., 2012). Also, during early gestation, the uterine 
lumen is in a low oxygenated state, due to matured vascular beds between the uterine and fetal 
circulations not being present (Barry and Anthony, 2008). This environment supports the 
utilization of fructose by the pre-implantation embryo due to their inability to metabolize 
reactive oxygen species (Johnson and Nasr-Esfahani, 1994). This was determined with in-vitro 
culture of bovine embryos, in which embryos cultured in a low oxygen environment (< 0.5% O2) 
had greater percent of blastocysts (28.5%) compared with the high oxygen environment (20% 
O2; 18.7% blastocysts; Balazubramanian et al., 2007). Additionally, it has been reported that 
glucose could only supply 49% of energy requirements of the fetus (Battaglia and Meschia, 
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1978), therefore, additional carbohydrates sources such as fructose or lactate must make up the 
balance. 
 
Utero-Placental Cationic Amino Acid Transporters 
The transport of cationic amino acids is mediated by five transporter systems: y+, y+L, b+, 
b0,+, and B0,+ (Hyde et al., 2003; Palacin  et al., 1998). In the case of amino acid transporters, 
lower case letters indicate sodium independent transport, and upper case letters indicate sodium-
dependent transport. Additionally, the super script indicates the charge of the molecule to be 
transported: “0” = neutral and “+” = cationic. The main transporters of interest to our research 
group are the high affinity, sodium-independent facilitative diffusion y+ transporters of arginine 
and lysine, CAT-1, CAT-2, and CAT-3 (SLC7A1, SLC7A2, and SLC7A3).  
Figure 1.6. SLC7 family members with 14 putative transmembrane domains (TM). (A) 
Snake model of hCAT-1: the yellow arrows point to residues identified to be important for 
transport function. The white wedges indicate the glycosylation sites. Taken with permission 
from Springer, Closs et al., (2006). 
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The CAT proteins have a 14 putative transmembrane domain with intracellular N- and C- 
termini (Figure 1.6; Albritton et al., 1989). The third extracellular loop contains a very well 
conserved glycosylation site across species for CAT-1, and CAT-2 contains two N-linked 
glycosylation sites in this loop (Wang et al., 1996). Proper function of these proteins does not 
tolerate many alterations in the protein sequence, therefore only very few polymorphisms can 
exist in the sequence, and the National Center for Biotechnology Information data base only lists 
silent single nucleotide polymorphisms (SNP: Closs et al., 2006). Cationic amino acid 
transporters are also, to varying degrees, trans-stimulated. In this case, the trans side of the 
membrane would be the intracellular, or transport channel pore facing the fetal system. This 
indicates that in utero-placental tissues, facilitative diffusion would occur up the concentration 
gradient, as the concentration of cationic amino acids in fetal fluids, is greater than that of 
maternal circulation (discussed in detail later). This is contradictory to facilitative diffusion 
membrane transporters which are known to transport down a concentration gradient in order to 
balance nutrient concentrations between the two sides of the membrane as discussed previously. 
However, in high proliferating tissues, such as the developing conceptus, nutrient sensing 
pathways such as mTOR, which is regulated by intracellular amino acid concentrations, is 
intrinsically linked to amino acid transport activity as well as intracellular amino acid 
metabolism (Hyde et al., 2003). This indicates that during fetal growth and development, when 
mTOR is being activated by cationic amino acids, CAT’s are thereby stimulated in order to 
increase the intracellular amino acid concentration, and continue the growth trajectory of the 
fetus through activation of nutrient sensing signaling pathways. 
Cationic amino acid transporter CAT-1 is capable of transporting arginine, lysine, and at 
low pH histidine (Closs et al., 2006). Transporter CAT-1 exhibits Km values for L-arginine and 
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L-lysine of 100-150µM, and is strongly stimulated by substrate on the trans-side of the 
membrane (Kim et al., 1991; Closs et al., 1997). A homozygous deletion of CAT-1 in mice is 
lethal, and results in a 25% reduction in size compared to a wild-type littermate, and death the 
day after birth (Perkins et al., 1997). The normal development of the CAT-1 knockout mouse 
before birth is hypothesized to be due to the expression of CAT-3 during embryogenesis and fetal 
development (Ito and Groudine, 1997; Nicholson et al., 1998). In sheep, knockout of CAT-1 
resulted in decreased arginine transport by 73%, arginine. Additionally arginine catabolites 
citrulline and ornithine, decreased by 76% and 40% respectively. Furthermore, decreases in 
arginine transport resulted in decreased ornithine decarboxylase, nitric oxide synthase (NOS), 
and polyamines which resulted in retarded growth development of the conceptus (Wang et al., 
2014). In sheep, CAT-1 expression increased 4-fold between days 10 and 14, and an additional 2-
fold between days 16 to 20 (Gao et al., 2009b). Additionally, CAT-1 expression was increased 
(1.8-fold greater than control) in the presence of P4, and tended to be increased in the presence 
of IFN-τ. In the peri-implantation bovine uterus, CAT-1 expression increased to d 16 of gestation 
(Forde et al., 2014). Additionally, expression of CAT-1 was greater in intercaruncular 
endometrium compared with the caruncular endometrium (Forde et al., 2014). Localization of 
CAT-1 in ovine utero-placental tissues was determined to be in the uterine LE, GE, and stromal 
cells, as well as in low levels in the trophectoderm and endoderm (Gao et al., 2009b).  
The second CAT transporter, CAT-2, has a ten-fold lower substrate affinity compared 
with CAT-1, and is less dependent on trans-stimulation (Closs et al., 1993; Kavanaugh et al., 
1994; Closs et al., 1997). In ewes, CAT-2 mRNA expression is greater in pregnant vs. cyclic 
ewes. Additionally, expression of CAT-2 increased 3.9-fold from d 10 to 14, and another 2.6-
fold and 4.2-fold on d 18 and 20, respectively (Gao et al., 2009b). In swine, mRNA expression of 
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CAT-2 in uterine endometria was greatest on d 12 of gestation (d of maternal recognition; 
Senger, 2012), and in placenta, was greatest on d 30 of gestation (nearing the end of the 1st 
trimester; Shim et al., 2012). In the bovine, expression of CAT-2 from d 10 to 20 of gestation, 
decreased with advancing gestation (Forde et al., 2014).  Expression of CAT-2 increased 4.1-fold 
in sheep in response to progesterone, and an additional 1.7-fold when co cultured with IFN-τ. 
These effects were only seen in the LE and GE of the uterus, and not in the stromal cells (Gao et 
al., 2009b). Expression of CAT-2 in response to P4 or IFN-τ in the bovine has yet to be 
elucidated. Cationic transporter CAT-2 was localized in the uterine LE and GE between days 16 
and 20 of gestation, and in the trophectoderm and extra embryonic endoderm of the conceptus 
between days 13 and 18 of gestation (Gao et al., 2009b). 
The final CAT transporter investigated within is CAT-3, which is widely expressed in 
embryonic tissues, and total knockout of this gene would most likely result in embryonic 
mortality due to interference with normal development (Closs et al., 2007). It is also 
hypothesized, that CAT-3 would be the main transporter during embryogenesis and fetal 
development, as a knockout of CAT-1 resulted in normal growth throughout gestation, however 
cause mortality one day post-parturition (Ito and Groudine, 1997; Nicholson et al., 1998). This 
theory has yet to be confirmed due to no CAT-3 knockout models having been established thus 
far. In the uterine endometrium of sheep, CAT-3 expression was not influenced by day of 
gestation or pregnancy status (Gao et al. 2009b). Expression of CAT-3 in response to 
progesterone or IFN-τ has yet to be established in the bovine or ovine model (Bazer et al., 2015). 
Localization of CAT-3 has been established in the trophectoderm and extra embryonic endoderm 
of the conceptus of sheep; however, no data has been reported as to the location in uterine 
endometrium (Bazer et al., 2015). 
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Although most emphasis will be placed on arginine, most amino acids are found in 
greater concentrations in fetal fluids, compared with maternal circulation (Kwon et al., 2003). 
Concentrations of arginine in serum (~ 0.13 mM) are less that what is found in uterine luminal 
fluid (~0.46-0.80 mM; Wu et al., 1996; Bazer et al., 2015). It has been determined that in porcine 
allantoic fluid, arginine concentrations are ~4.5 mM, and that arginine increases in concentration 
by 18-fold between days 30 and 40 of gestation with the total nitrogen accounting for ~50% of α-
amino acid nitrogen (Wu et al., 1996). In the ovine, total recoverable levels of arginine in uterine 
flushing’s was greater in pregnant vs. cyclic heifers, and increased 8-fold from d 10 to 16 of 
gestation (Gao et al., 2009c). In the bovine, total recoverable levels of arginine in uterine luminal 
fluid was nearly 2-fold greater on d 19 of gestation compared with d 10, 13, and 16 (Forde et al., 
2014). Additionally, lysine, which is also transported by CAT’s, is greater in ovine uterine 
flushing’s of pregnant ewes compared with cyclic ewes. Concentrations of lysine in pregnant 
ewes were also greater on d 14, 15, and 16 of gestation compared with earlier days (Gao et al., 
2009). Following a similar trend as arginine, lysine is also greater on d 19 of gestation in bovine 
uterine flushings, a nearly 2-fold increase in lysine concentration compared with all previous 
days (Forde et al., 2014). Interestingly, concentrations of arginine and lysine in bovine uterine 
flushing’s were lower on days 7 to 13 of gestation compared with the same days of the estrous 
cycle (Forde et al., 2014).  
As stated previously, arginine catabolism is an important activator of mTOR. Arginine 
can be metabolized by NOS directly to citrulline, and by doing so creates nitric oxide (NO). 
Additionally, arginine can be metabolized to ornithine via arginase, which creates urea as a by-
product. From here, ornithine decarboxylase 1 metabolizes ornithine to the polyamines: 
putrescine, spermidine, and spermine. Polyamines and NO are critical for implantation and 
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development of the conceptus through their activation of mTORC1 (Wu et al., 2009; Bazer et al., 
2011a). Feeding arginine-free diets during gestation in rats or inhibiting NO synthesis resulted in 
increased fetal resorption, intrauterine growth restriction, increased perinatal mortality, and 
decreased the number of live fetuses (Greenberg et al., 1997). One of the main reasons for these 
pregnancy failures, is due to the decreased abundance of products of arginine metabolism, NO 
and polyamines. These products, in addition to activating mTOR, are also essential for placental 
growth and angiogenesis, and therefore, for increasing uterine and placental-fetal blood flow 
(Wu et al., 2008). Polyamines and NO synthesis in both porcine and ovine placenta are greatest 
during early gestation when placental growth is most rapid (Kwon et al., 2004; Wu et al., 2005; 
Wu et al., 2006). Therefore, it is hypothesized that the use of arginine may prevent and treat 
IUGR in humans and animals.  
 
Statement of the Problem and Experimental Objectives 
 The long-term effects of restricted nutrient intake during early gestation include impaired 
placental development during establishment of the feto-maternal interface, leading to poor fetal 
growth and IUGR. The prenatal growth trajectory is sensitive to direct and indirect effects of 
maternal dietary intake from the earliest stages of embryonic life even though nutrient 
requirements for conceptus growth are negligible (Wallace et al., 2006; Robinson et al., 1999). 
Data indicates that production efficiency and health complications throughout life are 
‘programmed’ into the offspring due to poor fetal development associated with low birth weight 
(Wu et al., 2006; Caton and Hess 2010; Funston et al., 2010; Reynolds et al., 2010; Reynolds et 
al., 2012). In livestock, low birth weight is associated with preweaning death, which ranges from 
6.6 to 12.0 % for lambs (USDA, 2007; USDA, 2010) and calves (Azzam et al., 1993) in the U.S., 
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and can also influence profitability by reducing weaning weights (Corah et al., 1975) and 
increasing costs associated with health treatments of unthrifty animals. 
Fetal growth is vulnerable to maternal dietary nutrient deficiencies during the 1st trimester 
of gestation (Wu et al., 2004). During the first 50 days of gestation, organogenesis is taking 
place. This time period of gestation is a critical developmental window with significant cellular 
and tissue differentiation. Nutritional influences may alter the mammalian phenotype through 
affecting gene regulatory mechanisms involved in DNA synthesis and replication, thus 
“imprinting” potential susceptibilities to chronic disease and metabolic issues into the genome 
(Waterland and Jirtle, 2004). Currently, fetal undernutrition occurs in grazing livestock 
worldwide (Wu et al., 2004). Maternal undernutrition has been implicated in fetal growth 
restriction and altered placental growth, reduced amino acid and glucose transport, and increased 
apoptosis and autophagy, which overall can yield decreased fetal growth during gestation (Zhang 
et al., 2015). Before the establishment of hemotrophic nutrition, the placenta is developing and 
the fetus begins to utilize increasing quantities of glucose and amino acids (Groebner et al., 
2011). Thus, the expression of glucose and amino acid transporters in the utero-placenta 
becomes essential to the viability of the conceptus. Therefore, we studied the utero-placental 
glucose and fructose transporters GLUT1, GLUT3, GLUT5, and GLUT14 (SLC2A1. SLC2A3, 
SLC2A5, and SLC2A14). The amino acid transporters investigated are CAT-1, CAT-2, and CAT-3 
(SLC7A1, SLC7A2, and SLC7A3) whose substrates are cationic amino acids such as arginine and 
lysine, which are directly linked to angiogenesis and cell proliferation. Understanding how day 
of gestation affects gene expression and nutrient concentrations in bovine fetal fluids, as well as 
the effects of compromised maternal nutrition on the mRNA expression of nutrient transporters 
and subsequently nutrient concentrations in bovine utero-placental tissues, may lead to novel 
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approaches to feeding heifers in order to mitigate spontaneous embryonic abortion, and lead to 
increased production efficiencies. 
With this in mind, we tested the hypothesis that mRNA for glucose and cationic amino 
acid transporters in utero-placental tissues would be differentially expressed due to day of 
gestation and maternal nutritional status, and that the concentrations of glucose, fructose, and 
cationic amino acids would be different due to day of gestation and maternal nutritional status. 
Therefore the objectives of these studies were to 1) Isolate glucose and cationic amino 
acid transporters in utero-placental tissues and determine the effect of day of gestation on their 
respective mRNA expression, while establishing key dates of gestation for further analysis 2) 
Determine the effects of aberrant maternal nutrition on the mRNA expression of glucose, 
fructose, and cationic amino acid transporters in bovine utero-placental tissues on days 16, 34, 
and 50 of gestation, and 3) Determine the effects of aberrant maternal nutrition on the 
concentrations of nutrients in maternal and fetal fluids from days 16 to 50 of gestation. 
The following chapters of this thesis will be divided by these experimental objectives: 1) 
Establishing the pattern of mRNA expression over the first 50 days of gestation in Chapter 2, 2) 
Confirming presence of, and isolating novel glucose transporters GLUT3 and GLUT14 in bovine 
utero-placental tissues while simultaneously elucidating their relative expression as influenced 
by aberrant maternal nutrition in Chapter 3, 3) Determining the effects of maternal nutritional 
status on the mRNA expression of GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 as well as 
concentrations of glucose, fructose, and cationic amino acids in maternal and fetal fluids on days 
16, 34, and 50 of gestation in Chapter 4, and 4) Concluding with a general discussion and future 
directions in Chapter 5.  
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CHAPTER 2: NUTRIENT TRANSPORTERS IN BOVINE UTERO-PLACENTAL 
TISSUES ON DAYS 16 TO 50 OF GESTATION1 
Abstract 
During early gestation, nutrients are transported to the developing embryo via 
transporters in the uterine endometrium and chorioallantois. In the present study, we examined 
glucose transporters, GLUT1 and GLUT3, and the cationic amino acid transporters, SLC7A1, 
SLC7A2, and SLC7A3, in order to test the hypotheses that: 1) relative mRNA expression of 
transporters would be different among utero-placental tissue type as gestation progresses; and 2) 
concentrations of glucose and cationic amino acids would be different among target sites 
(placental compartments, serum, histotrophic) and days of gestation. To test these hypotheses, 
crossbred Angus heifers (n = 46), were synchronized, bred via AI and then 
ovariohysterectomized on d 16, 22, 28, 34, 40, or 50 of gestation (n = 5 to 9/d), or were not bred 
and ovariohysterectomized on d 16 of the synchronized estrous cycle (n = 7) to serve as non-
pregnant (NP) controls. Utero-placental tissues (maternal caruncule, CAR; intercaruncular 
endometrium, ICAR; and fetal membranes, FM [chorioallantois, d 22 and later]) were collected 
from the uterine horn ipsilateral to the Corpus Luteum immediately following 
ovariohysterectomy. Relative mRNA expression of the glucose transporters and cationic amino 
acid transporters was determined for each tissue from d 16 to 50 of gestation and NP controls. 
Chorioallantoic, amniotic, and plasma fluids were collected from heifers on d 40 and 50 of  
1The material in this chapter was co-authored by M. S. Crouse, K. J. McLean, M. R. Crosswhite, 
L. P. Reynolds, C. R. Dahlen, B. W. Neville, P. P. Borowicz, and J. S. Caton. It has been 
accepted for publication by the Journal of Animal Science, doi: 10.2527/jas.2016-0857. M. S. 
Crouse and K. J. McLean had primary responsibility for collecting samples. M. S. Crouse was 
the primary developer of the conclusions that are advanced here. M. S. Crouse also drafted and 
revised all versions of this chapter. J. S. Caton served as proofreader and checked the math in the 
statistical analysis conducted by M. S. Crouse 
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gestation to determine concentrations of glucose and cationic amino acids. Expression of GLUT1 
and SLC7A2 showed a tendency (P < 0.10) towards being greater on d 16 ICAR, and d 34 ICAR, 
respectively. Day × tissue interactions (P < 0.05) were present for GLUT3, SLC7A1 and 
SLC7A3. Expression of GLUT3 was greater in d 50 CAR, SLC7A1 was greater on d 34 in ICAR, 
and SLC7A3 was greater in CAR tissue on d 34 compared with all other tissues and days of 
gestation. Glucose concentrations tended (P = 0.10) to be impacted by a day × fluid interaction. 
A day × fluid interaction (P = 0.01) for arginine concentration was observed with greater 
concentrations in allantoic fluid on d 40 compared with all other days and fluid types. These data 
support our hypothesis that glucose and cationic amino acid transporters differ in their level of 
mRNA expression due to day of gestation and utero-placental tissue type. In addition, 
concentrations of nutrients were impacted differentially by day, target site, and/or their 
respective interaction. 
Key words: cationic amino acids, early gestation, glucose, nutrient transporters, utero-placental 
 
Introduction 
 Currently, fertilization rates for first service AI are approximately 90% in beef heifers 
(Bridges et al., 2013); however, by d 30 of gestation, only 50 to 60% of heifers are gestating 
viable embryos. Moreover, Thatcher et al. (1994) indicated that up to 80% of all embryonic loss 
occurs before d 40 of gestation. Nutrient transport across the placenta is the only method of 
nutrient flux to the embryo during early gestation, and expression of transporters in the 
interplacentomal region of the placenta provides nutrients via histotroph to the early conceptus 
(Wooding and Flint, 1994). The presence of nutrient transporters and nutrient flow to the embryo 
and placenta is crucial for proper development and growth. During the preimplantation period 
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through the establishment of hemotrophic nutrition, the conceptus utilizes increasing quantities 
of glucose and amino acids supplied by uterine histotroph (Gardner, 1998; Groebner et al., 2011; 
Bazer et al., 2014). Histotroph is a mixture of enzymes, growth factors, adhesion proteins, 
cytokines, hormones, transport proteins, amino acids, and saccharides which are supplied from 
the luminal, superficial glandular and deep glandular epithelium of the uterine endometrium 
(Bazer, 1975; Roberts et al., 1988; Wang et al., 2014). Inappropriate composition of uterine 
histotroph may cause improper development of conceptuses (Wang et al., 2014). Thus, the 
expression and function of glucose and amino acid transporters in the utero-placenta becomes 
essential to the viability of the conceptus. In this study, we tested the hypotheses that; 1) relative 
mRNA expression of transporters would be differentially expressed due to day of advancing 
gestation, and that transporters would be differentially expressed due to utero-placental tissue 
type and 2) concentrations of glucose and cationic amino acids would be different due to day of 
gestation and maternal or fetal fluid type. 
 
Materials and Methods 
All animal procedures were approved by the North Dakota State University Institutional 
Animal Care and Use Committee. 
Animals 
 Crossbred Angus heifers (n = 46, ~15 mo of age; BW = 362.3 ± 34.7 kg ADG = 0.22 kg) 
were fed once daily, grass hay (DM: 90%, CP: 10.7%, ADF: 38.9%) and supplemented with 
cracked corn (DM: 90%, CP: 9.8%, ADF: 3.3%) via a Calan Head Gate System (American 
Calan, Northwood, NH) and were individually fed to gain 0.25kg/d. Heifers were obtained from 
the Central Grasslands Research Extension Center (Streeter, ND; 2.5 h southwest of Fargo), and 
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housed at the NDSU Animal Nutrition and Physiology Center in group pens with six heifers in 
each pen. All heifers were exposed to the 5-d CO-Synch + CIDR estrus synchronization protocol 
(Bridges et al., 2008). Seven heifers were not inseminated to serve as non-pregnant (NP) 
controls, but received ovariohysterectomy on d 16 of the synchronized estrous cycle. The 
remaining heifers were AI bred to a single sire and ovariohysterectomized on d 16 (n = 9), d 22 
(n = 6), d 28 (n = 6), d 34 (n = 7), d 40 (n = 6), or d 50 (n = 5) of gestation. Heifer selection for 
ovariohysterectomy on d 16 of gestation was random selection based on inability to confirm 
pregnancy via ultrasonography, and upon hysterectomy, heifers without fetal membranes were 
removed from the study. Heifer selection on d 22 was based upon no observed estrus by d 21 and 
localization of a Corpus Luteum and fetus/fetal fluids via ultrasonography. Heifers on d 28 
through 50 of gestation were selected for ovariohysterectomy after confirmed pregnant via 
ultrasonography. 
Sample Collection and Analysis 
Ovariohysterectomy procedures were conducted as described by McLean et al (2016). 
Briefly, ovariohysterectomy was conducted as a standing procedure, with a left flank incision. 
Uterine, and ovarian arteries were sutured and ligated, along with sutures being placed along the 
cervix. The uterus was clamped caudal to the bifurcation, and incised along the clamp, thereby 
collecting the entire uterine body and horns, along with the attached ovaries. Immediately 
following ovariohysterectomy, utero-placental tissues (caruncle, CAR; intercaruncular 
endometrium, ICAR; and fetal membranes, FM [chorioallantois, d 22 and later]) were separated 
and collected individually from the uterine horn ipsilateral to the Corpus Luteum, as previously 
described (Grazul-Bilska et al., 2010, 2011). Fetal membranes were collected only from d 22 and 
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later due to limited tissue volume present on d 16 and absence of FM in NP controls. Once 
collected, all tissues were snap frozen in liquid nitrogen cooled isopentane, and stored at -80°C.  
 Real-time quantitative PCR (qPCR) was done on  CAR, ICAR, and FM samples to 
determine mRNA expression of glucose transporter 1 (GLUT1-facilitative glucose transporter 
which is found in most tissues throughout the body and is ubiquitous across mammalian species), 
glucose transporter 3 (GLUT3- Facilitative glucose transporter specifically known for neural and 
placental glucose transport), and cationic amino acid transporter 1, 2, and 3 (SLC7A1, SLC7A2, 
and SLC7A3- All of which are facilitated diffusion arginine and lysine transporters). The RNA 
was extracted and purified using RNeasy Mini Kit (Qiagen, Valencia, CA), total quantity of 
RNA was determined using Take3 module of a Synergy H1 Microplate Reader (BioTek, 
Winooski, VT), and cDNA was synthesized using QuantiTect Reverse 2.1 Transcription Kit 
(Qiagen). Primer sequences (Table 2.1) for glucose and amino acid transporters were obtained 
from GenBank (GenBank, Bethesda, MD). The cDNA dilutions were determined by primer 
validation for each gene and tissue type across stages of gestation. For PCR, dilutions of 1:100 
were used for GLUT1 and SLC7A1, and 1:10 for GLUT3, SLC7A2, and SLC7A3. Gene 
expression was quantified using a 7500 Fast Real-Time PCR System (Applied Biosystems, 
Grand Island, NY) with SYBR Green Master Mix (Bio-Rad Laboratories, Hercules, CA); 18µL 
total for GLUT1 and SLC7A1, and 15 µL total for GLUT3, SLC7A2, and SLC7A3. 
 Plasma samples were collected via jugular venipuncture at time of ovariohysterectomy 
using 10 mL heparin vacutainer tubes (Becton Disckinson HealthCare, Franklin Lakes, NJ), and 
centrifuged at 1,500 × g for 30 minutes. Plasma was separated from blood constituents and 
stored at -20°C. Allantoic Fluid (ALF) was collected by isolating the embryo within the uterine 
horn, and extracting 10 mL of fluid from the chorioallantoic sac using a 22 gauge needle 
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(Medtronic, Minneapolis, MN) to prevent rupture of the sac. Amniotic Fluid (AMF) was 
collected using a 22 gauge needle (Medtronic) inserted through the amnion with suction applied 
via syringe after the amniotic sac containing the embryo was visualized; 5 mL of fluid was 
collected from the d 40 embryo and 10 mL from d 50 embryos. Allantoic and amniotic fluids 
were only collected on d 40 and 50 of gestation. Once collected, all fluids were snap frozen in 
liquid nitrogen cooled isopentane and stored in -20°C. 
 Arginine, ornithine, citrulline, and lysine concentrations were determined using 
ACQUITY UPLC System (Waters Corporation, Milford, MA). For UPLC, 250 µL of fluid was 
used for plasma, ALF, and AMF. The MassTrac Amino Acid Analysis System for Waters UPLC 
was used to determine the full profile of amino acids in physiological fluids. Derivatization 
chemistry for physiological samples is a precolumn method and is based on a derivatizing 
reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC), which converts both 
primary and secondary amino acids to stable chromophores for UPLC detection. Glucose 
concentrations were determined using Infinity Glucose Hexokinase Liquid Stable Reagent 
(Fisher Diagnostics, Middletown, VA), and analyzed with a Synergy H1 Microplate Reader 
(BioTek, Winooski, VT). For glucose determination, 5 µL of fluid was used for plasma, ALF, 
and AMF with 250µL of reagent (Intraplate CV = 2.99; Interplate CV = 2.91).  
Statistical Analysis 
 Day of Gestation CAR and ICAR.  
 Data were analyzed for day of gestation effects using the GLM procedure of SAS 9.3 
(SAS Inst. Inc., Cary, NY), with individual heifer serving as the experimental unit. Means were 
separated using the LSMEANS procedure of SAS and P-values ≤ 0.05 were considered different. 
Effect of day of gestation was determined for each individual tissue (CAR, ICAR).
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Table 2.1. Primer Sets used for real-time quantitative reverse-transcription PCR 
Gene1 
Product 
size 
(bp) Forward primer (5'-3') Reverse Primer (5'-3') 
GenBank 
Accession No. 
GLUT1 2533 CGGCTGCCCTGGATGTC GCCTGGGCCCACTTCAAA NM_174602 
GLUT3 1404 CAAGTCACAGTGCTAGAGTCTTTC GGAGAGCTGGAGCATGATAGAGAT XM_001256170 
SLC7A1 695 CCGATAATCGCCACCTTAACCT ACCAGGTCCTTCAGGTCGAA DQ399522 
SLC7A2 490 AAGGAAATGTGGCAAACT TTGAAAAGCAACCCATCCTC XM_865568.2 
SLC7A3 473 TACCAGCCTCTTGGGCTCTA AAAGCAGTGGAATGGACCAC BC126655 
1GLUT1 and GLUT3- Glucose transporter solute carrier family 2 member 1 and 3. SLC7A1, SLC7A2, and SLC7A3- Cationic 
amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3. 
5
0
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 Day of Gestation FM. 
 Data were analyzed for day of gestation effects using the GLM procedure of SAS 9.3 
(SAS Inst. Inc., Cary, NY), with individual heifer serving as the experimental unit. Means were 
separated using the LSMEANS procedure of SAS and P-values ≤ 0.05 were considered different. 
Due to no NP control for fetal membranes, data is given as ΔCt values after being normalized to 
β-actin. Lowest ΔCt would yield highest total expression after second normalization to a control; 
however, since there is no FM in a non-pregnant animal, there is no second normalization for 
effect of day of gestation. Therefore in analysis, a lower ΔCt will be described as having the 
higher level of expression. 
 Day × Tissue. 
In order to evaluate the level of expression of glucose and cationic amino acid 
transporters between CAR, ICAR, and FM from d 16 to 50 of gestation, data were analyzed for 
an interaction between day of gestation (d 16, 22, 28, 34, 40, or 50) and utero-placental tissue 
type (CAR, ICAR, and FM) using the GLM procedure of SAS 9.3 (SAS Inst. Inc., Cary, NY), 
with individual heifer serving as the experimental unit. Means were separated using the 
LSMEANS procedure of SAS and P-values ≤ 0.05 were considered different. Interactions were 
determined across utero-placental tissue type and day of gestation utilizing NP endometrium 
sample as the baseline. If no significant interaction was present, main effect of tissue was 
analyzed within gene of interest. Effect of tissue was determined using the GLM procedure of 
SAS 9.3 (SAS Inst. Inc., Cary, NY), with individual heifer serving as the experimental unit. 
Means were separated using the LSMEANS procedure of SAS and P-values ≤ 0.05 were 
considered different. The effect of day of gestation given is not an accurate representation of 
significance within gene due to a magnitude change compared with NP endometrium, and was 
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therefore conducted as discussed previously to provide an effect of d of gestation without an 
increased magnitude yielding significance. 
Day × Fluid.  
Data were analyzed for an interaction between day of gestation and maternal or fetal fluid 
type using the GLM procedure of SAS 9.3 (SAS Inst. Inc., Cary, NY), with individual heifer 
serving as the experimental unit. Means were separated using the LSMEANS procedure of SAS 
and P-values ≤ 0.05 were considered different.  
  
Results 
Effects of Day of Gestation 
 CAR. 
 Expression of GLUT1 was greater (P < 0.01) at d 16 (7.8-fold increase over NP) 
compared with d 22 (4.3 fold increase over NP), which was greater (P < 0.05) than the remaining 
days of early pregnancy and NP (SEM = 1.0; Table 2.2). Expression of GLUT3 was greater (P = 
0.01) on d 50 (13.68-fold increase over NP) of gestation compared with NP and d 16, 22, 28, and 
40 of gestation (SEM = 2.3; Table 2.2). Additionally, d 34 was greater (9.13-fold increase over 
NP; P ≤ 0.05) compared with NP and d 16 (Table 2.2). Relative expression of SLC7A1 was 
greater (P ≤ 0.05) on d 28, 34, and 40 (5.12, 6.82, and 5.10-fold increase over NP) compared 
with NP, d 16, 22, and 50 of gestation (SEM = 0.9; Table 2.2). Day of gestation did not influence 
SLC7A2 expression (P = 0.20). Expression of SLC7A3 was greater (P = 0.01) on d 16 (6.9-fold 
greater than NP) compared with NP and all other days of gestation evaluated (SEM = 1.7; Table 
2.2).  
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ICAR.  
 Expression of GLUT1 in ICAR followed a similar pattern as in CAR, with d 16 (13.24-
fold greater than NP) being greater (P < 0.01) than all other days measured (SEM = 2.2; Table 
2.2). Additionally, d 22 GLUT1 expression was greater (6.07-fold greater than NP; P ≤ 0.05) 
than NP on d 34, 40, and 50 of gestation. Relative expression of GLUT3 tended (P = 0.06) to be 
greater on d 28 and 34 compared with NP. On d 34 of gestation, relative expression of SLC7A1 
was 16-fold greater (P < 0.01) than NP, and on d 40 was still greater (12.02-fold greater than NP; 
P ≤ 0.05) than NP or d 16, 22, 28, and 50 of gestation (SEM = 2.0; Table 2.2). Expression of 
SLC7A2 was greater (P = 0.02) on d 34 (10.25-fold greater than NP) compared with NP and all 
other days except d 28 (7.84-fold greater than NP) which was greater compared with NP and d 
16, 22, and 50 (SEM = 3.1; P ≤ 0.05; Table 2.2). Expression of SLC7A3 was greater (P ≤ 0.05) 
on d 28 (1.87-fold greater than NP) compared with d 16, 22, and 50 (SEM = 0.5; Table 2.2). 
Additionally SLC7A3 in NP, d 34, and 40 heifers was greater (P ≤ 0.05) compared with d 16 and 
22 (Table 2.2).   
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 FM.  
 The expression of GLUT1 was greater (P < 0.01; Table 2.3) on d 34 and 50 (5.58 and 
5.32 ΔCt) compared with d 22 and 28. Additionally, d 40 (5.84 ΔCt) was intermediate and 
greater (P ≤ 0.05) compared with d 22 (SEM = 0.3; Table 2.3).  Expression of GLUT3 in FM 
was similar among all days evaluated (P = 0.72; Table 2.3). The ΔCt of SLC7A1 was greater (P 
< 0.01) on d 34 and 50 (6.99 and 7.05 ΔCt respectively; Table 2.3) compared with d 22, 28, and 
Table 2.2 Level of expression of nutrient transporters GLUT1, GLUT3, SLC7A1, SLC7A2, and 
SLC7A3 in CAR and ICAR tissue in non-pregnant controls and from d 16 to 50 of gestation 
   
  
    
Day of 
Gestation2 
    
  
Tissue3 
Gene of 
Interest 
  
NP 16 22 28 34 40 50 SEM4 
P - 
value5 
 
GLUT1 1.00a 7.77c 4.34b 2.06a 1.38a 1.20a 1.70a 1.0 < 0.0001 
 
GLUT3 1.00a 3.89a 5.62ab 4.80ab 9.13bc 4.93ab 13.68c 2.3 0.01 
CAR SLC7A1 1.00a 1.54a 1.99a 5.12b 6.82b 5.10b 0.98a 0.9 < 0.0001 
 
SLC7A2 1.00 2.38 1.37 0.68 3.24 2.95 0.35 1.0 0.2 
 
SLC7A3 1.00a 6.89b 0.69a 0.42a 0.52a 0.54a 0.14a 1.7 0.01 
 
GLUT1 1.00a 13.24c 6.07b 2.48ab 1.65a 1.04a 0.66a 2.2 < 0.0001 
 
GLUT3 1.00 0.93 1.67 4.32 4.90 3.51 0.73 1.7 0.06 
ICAR SLC7A1 1.00a 2.03a 1.63a 6.30b 16.03d 12.02c 5.73b 2.0 < 0.0001 
 
SLC7A2 1.00a 1.25a 1.23a 7.84bc 10.25c 4.08ab 2.15a 3.1 0.02 
  
SLC7A3 
  
1.00abc 0.50a 0.20a 1.87c 1.49bc 1.46bc 0.61ab 0.5 0.03 
1Gene of Interest = GLUT1 and GLUT3 - Glucose transporter solute carrier family 2 member 1 and 
3. SLC7A1, SLC7A2, and SLC7A3 - Cationic amino acid transporters of arginine and lysine, solute 
carrier family 7 member 1, 2, and 3. 
2Day of Gestation = number of days after insemination. Day 0 is non-bred non-pregnant control 
and serves as the baseline of expression for that gene. Each gene expression is given as a fold 
change in relation to NP level of expression.  
3CAR - caruncular tissue (caruncles taken from the uterine horn ipsilateral to the CL), ICAR - 
inter-caruncular tissue (endometrial tissue not including caruncles; taken from uterine horn 
ipsilateral to the CL) 
4The average SEM was used within gene. NP n = 7, d 16 n = 9, d 22 n = 6, d 28 n = 6, d 34 n = 7, d 
40 n = 6, d 50 n = 5. 
5Probability values for effect of day on level of expression of individual genes.  
a-cMeans within a row without a common superscript differ (P < 0.05). 
55 
 
40. Additionally, d 28 (8.16 ΔCt) was greater (P ≤ 0.05) compared with d 22, and d 40 being 
equivalent to both d 22 and 28 (SEM = 0.4; Table 2.3). The expression of SLC7A2 was similar 
throughout early gestation (~5.5 ΔCt; P = 0.14; Table 2.3). The cationic amino acid transporter 
SLC7A3 tended (P = 0.08) to be greater in expression on d 28 (9.64 ΔCt) of gestation (Table 
2.3). 
 Day × Tissue Interaction 
 When using NP endometrium as a baseline level of expression of 1.0, a tendency (P = 
0.10) for a day × tissue interaction for GLUT1 was observed.  In addition, a main effect of tissue 
was observed with mean expression of GLUT1 in CAR and ICAR (5.90 and 6.53 fold greater 
than NP endometrium, respectively; SEM = 0.75) being greater (P < 0.01) than FM (Table 2.4). 
Expression of GLUT3 was impacted by a day × tissue interaction (P = 0.01) with d 50 CAR 
(15.04-fold greater than NP endometrium), which was greater than CAR on all other days or  
ICAR and FM on all days (Table 2.4). Cationic amino acid transporter SLC7A1 expression was 
greater in day × tissue interaction (P < 0.01) on d 34 in ICAR (11.03-fold greater than NP 
endometrium) compared with d 40 ICAR (8.27-fold greater than NP endometrium), which was 
greater (P ≤ 0.05) than ICAR on all other days or CAR and FM on all days (Table 2.5). 
Expression of SLC7A2 tended (P = 0.07) to be affected by a day × tissue interaction. 
In addition, a main effect of tissue was observed in which expression of CAR and ICAR 
was greater (11.8 and 7.7-fold greater than NP endometrium, respectively; P < 0.01) compared 
with FM (2.39 fold greater than NP endometrium; SEM = 1.69; Table 2.5). Relative mRNA 
expression of SLC7A3 was impacted by day × tissue interaction, being greater (P = 0.02) in CAR 
on d 16 (28.05-fold greater than NP endometrium) compared to CAR on all other days or ICAR 
or FM on all days (SEM = 4.5; Table 2.5).  
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Table 2.3 Level of expression of nutrient transporters GLUT1, GLUT3, SLC7A1, SLC7A2, 
and SLC7A3 in fetal membranes from d 22 to 50 of gestation.1 Due to no second 
normalization, data is presented as a ΔCt value.2 
 
  
Day of 
Gestation3 
    
    Gene of 
Interest 
22 28 34 40 50 
  
SEM4 
  
P - value5 
      
 
 
  GLUT1 6.72a 6.35ab 5.58c 5.84bc 5.32c 
 
0.3 
 
< 0.01 
GLUT3 6.38 6.06 6.29 6.35 5.66 
 
0.4 
 
0.72 
SLC7A1 9.93a 8.16b 7.05c 8.86ab 6.99c 
 
0.4 
 
< 0.01 
SLC7A2 6.76 6.05 6.09 4.77 5.57 
 
0.6 
 
0.14 
SLC7A3 12.25 9.64 10.4 11.61 13.08  0.9   0.08 
1GLUT1 and GLUT3 - Glucose transporter solute carrier family 2 member 1 and 3. SLC7A1, 
SLC7A2, and SLC7A3 - Cationic amino acid transporters of arginine and lysine, solute 
carrier family 7 member 1, 2, and 3.  
2Lower ΔCt value indicated higher level of expression. 
3Day of Gestation = number of days after insemination. Values for expression of genes are 
provided as ΔCt values for that gene after being normalized to β-actin.  
4The average SEM was used within gene. d 22 n = 6, d 28 n = 6, d 34 n = 7, d 40 n = 6, d 50 
n = 5. 
5Probability values for effect of day on level of expression of individual genes. 
a-cMeans within a row without a common superscript differ (P < 0.05).  
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Table 2.4 Level of expression of nutrient transporters GLUT1 and GLUT3 in CAR, ICAR, and FM tissues in non-pregnant (NP) controls 
and from d 16 to 50 of gestation compared with non-pregnant endometrium tissue.1  
  
Day of Gestation2 
  
P- value3 
Item 
  NP 16 22 28 34 40 50 
Tissue 
Means4 
SEM5 Day Tissue 
Day  
×  
Tissue 
         
 
    GLUT1 
       
 1.9 < 0.01 0.02 0.10 
CAR 0.719 18.929 9.494 3.108 3.009 2.343 3.715 5.90h 
    ICAR 1.711 24.597 10.391 3.297 2.823 1.781 1.131 6.53h 
    FM - - 0.590 0.642 1.106 0.936 1.307 0.92g 
    GLUT3 
       
 2.7 < 0.01 < 0.01 0.01 
CAR 1.308abc 6.412abcd 9.254d 7.911bcd 15.044e 8.127cd 24.475f 10.36 
    ICAR 0.258a 0.892ab 1.598abc 4.126abcd 5.339abcd 3.353abcd 1.183abc 2.39 
    FM - - 1.407abc 2.105abc 1.956abc 1.774abc 2.494abcd 1.95 
    1GLUT1 and GLUT3 - Glucose transporter solute carrier family 2 member 1 and 3. CAR - caruncular tissue (caruncles taken from the 
uterine horn ipsilateral to the CL), ICAR - inter-caruncular tissue (endometrial tissue not including caruncles; taken from uterine horn 
ipsilateral to the CL), and FM - chorioallantois d 22 and later. 
2Day of Gestation = number of days after insemination. The NP equals a non-bred, non-pregnant control d 0 and serves as the baseline of 
expression for that gene. Each gene expression is given as a fold change in relation to NP endometrium level of expression. 
3Probability values for the effect of day, tissue, and day × tissue on level of expression of individual genes. 
4The mean gene expression for the tissue across all days of gestation. 
5The average SEM was used within gene. NP- n = 7, d 16 n = 9, d 22 n = 6, d 28 n = 6, d 34 n = 7, d 40 n = 6, d 50 n = 5. 
a-fMeans within a gene without a common superscript differ in day × tissue (P < 0.05).  
g-h Means different across tissue (P < 0.05). 
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   Day × Fluid Interaction  
 When comparing concentrations of metabolites on d 40 and 50 across maternal plasma, 
allantoic, and amniotic fluids, glucose tended (P = 0.10) to be affected by a day × fluid 
interaction. A main effect of day determined glucose concentrations to be greater (P = 0.05) on d 
50 when compared to d 40 of gestation (2.76 vs. 2.35mM, respectively; SEM = 0.14; Table 2.6). 
Concentration of glucose in plasma was greater (P < 0.01) than both allantoic and amniotic fluid 
(4.6 vs. 1.6, and 1.50, respectively; SEM = 0.17; Table 2.6). The concentration of arginine 
showed a significant day × fluid interaction (P < 0.01), with allantoic fluid having greater (P < 
0.01) concentrations of arginine on d 40 compared with amniotic and plasma fluids on all other 
days (Table 2.6). Concentrations of ornithine, the first catabolite of arginine, were not affected 
by a day × fluid interaction (P = 0.51), but were greater (P < 0.01) in allantoic fluid compared 
with plasma and amniotic fluids (153.58 vs. 70.43 and 69.43 µmol/L; SEM = 7.76; Table 2.6). 
Citrulline, which is an additional catabolite of arginine, was not affected by a day × fluid 
interaction (P = 0.13). There was a main effect of fluid, in which citrulline was greater (P < 
0.0001) in maternal plasma, intermediate in allantoic fluid, and least in amniotic fluid as it was 
undetected by the UPLC (69.36, 22.58 µmol/L, and undetected, respectively; SEM = 3.24; Table 
2.6).  
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Table 2.5  Level of expression of nutrient transporters SLC7A1, SLC7A2, and SLC7A3 in CAR, ICAR, and FM tissues in non-pregnant 
(NP) controls and from d 16 to 50 of gestation compared with non-pregnant endometrium tissue.1  
  
Day of Gestation2 
  
P-value3 
Item   NP 16 22 28 34 40 50 
Tissue 
Means4 SEM5 Day Tissue 
Day  
×  
Tissue 
             
 
SLC7A1 
         
0.8 < 0.01 < 0.01 < 0.01 
CAR 
 
0.671a 1.291a 1.661ab 4.276def 5.699f 4.263cdef 0.687a 2.65 
   
 
ICAR 
 
0.688a 1.393a 1.118a 4.330ef 11.026h 8.267g 3.944bcdef 4.40 
   
 
FM 
 
- - 0.086a 0.324a 0.624a 0.233a 0.624a 1.89 
   
 
             
 
SLC7A2 
         
4.3 < 0.01 < 0.01 0.07 
CAR 
 
5.718 7.625 7.143 4.25 16.904 10.189 1.841 7.67h 
   
 
ICAR 
 
1.098 4.856 4.777 19.137 28.267 15.914 8.388 11.78h 
   
 
FM 
 
- - 1.077 2.761 1.657 3.861 2.605 2.39g 
   
 
             
 
SLC7A3 
         
4.5 < 0.01 0.40 0.02 
CAR 
 
2.39a 28.049b 2.816a 1.69a 2.132a 2.191a 0.697a 5.71 
   
 
ICAR 
 
1.55a 0.771a 0.311a 2.9a 2.306a 2.267a 0.203a 1.58 
   
 
FM   - - 0.61a 1.603a 1.949a 0.634a 0.212a  1.00         
1SLC7A1, SLC7A2, and SLC7A3 - Cationic amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3.  
CAR - caruncular tissue (caruncles taken from the uterine horn ipsilateral to the CL), ICAR - inter-caruncular tissue (endometrial tissue 
not including caruncles; taken from uterine horn ipsilateral to the CL), and FM - chorioallantois d 22 and later. 
2Day of Gestation = number of days after insemination. The NP equals a non-bred, non-pregnant control d 0 and serves as the baseline of 
expression for that gene. Each gene expression is given as a fold change in relation to NP endometrium level of expression. 
3Probability values for the effect of d, tissue, and d × tissue on level of expression of individual genes. 
4The mean gene expression for the tissue across all days of gestation. 
5The average SEM was used within gene. NP- n=7, d16 n = 9, d22 n = 6, d28 n = 6, d34 n = 7, d40 n = 6, d50 n = 5. 
a-fMeans within a gene without a common superscript differ in d × tissue (P < 0.05).  
g-h Means different across tissue (P < 0.05). 
5
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Lysine did not show a significant day × fluid interaction (P = 0.31), but showed a main effect of 
fluid, being greater (P < 0.01) in allantoic fluid, intermediate in amniotic fluid, and least in 
plasma (634.50, 236.95, and 99.86 µmol/L, respectively; SEM = 28.37; Table 2.6). 
 
Discussion 
 This study is the first to report changes in the mRNA expression of key glucose and 
cationic amino acid transporters in bovine utero-placental tissues from before maternal 
recognition of pregnancy and implantation through the embryonic stage of development. Results 
of this study indicate that the expression of glucose and cationic amino acid transporters in 
bovine utero-placental tissues changes dramatically during the first 50 days of gestation in beef 
heifers. In the current report, facilitative glucose transporters (GLUT1 and GLUT3) and cationic 
amino acid transporters (SLC7A1, SLC7A2, and SLC7A3) were all present in uterine tissue, CAR 
and ICAR, and developing placenta during the first 50 d of gestation as well as in NP uterine 
tissues. Additionally, these data also demonstrate an effect of day of gestation on the mRNA 
expression of these genes in bovine utero-placental tissues, as well as maternal and fetal fluid 
type on the concentration of glucose and arginine.  
 In sheep endometrium, temporal changes of GLUT1 expression were similar during early 
gestation in which GLUT1 was greater during maternal recognition of pregnancy (Gao et al., 
2009a) as reported herein. In the Holstein however, no effects of day of gestation were seen in 
the endometrium from d 28 to 42 of gestation (Lucy et al., 2012).  Localization of GLUT1 in the 
ovine endometrium has been determined to be in the luminal (LE) and superficial glandular 
epithelium (sGE) of the ovine uterus (Gao et al., 2009a). In the ovine, GLUT1 expression was 
increased 4.2-fold with progesterone (P4) treatment, and 2.1-fold with interferon tau (IFN-τ) 
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infusion (Gao et al., 2009a). In-situ hybridization and immunohistochemistry revealed that the 
effects of P4 and IFN-τ on GLUT1 were mainly localized to the LE and sGE (Gao et al., 2009a). 
It would be of interest in future studies to determine GLUT1 location in bovine uterine tissues 
and determine if GLUT1 is a progesterone induced and interferon stimulated gene as it is in the 
ovine. Expression of GLUT1 in bovine FM increased in level of expression from d 22 to 50 
following a differential pattern of expression as seen in maternal uterine tissues. This pattern of 
expression is also different than what was seen in Holstein cows, in which mRNA concentration 
of GLUT1 decreased from d 28 to 42 of gestation (Lucy et al., 2012).  
 In contrast to the pattern of expression for GLUT1 in bovine endometrium, GLUT3 in 
CAR increased throughout gestation reaching peak level of expression on d 50. In the Holstein 
however, GLUT3 mRNA was similar from d 28 to 42 of gestation in caruncular tissue (Lucy et 
al., 2012). Localization of GLUT3 in uterine tissue was established in the rat, in which GLUT3 
was localized in both uterine stroma (dense connective tissue), and uterine epithelium, increasing 
in abundance as gestational day increased (Korgun et al., 2001).  Expression of GLUT3 in FM 
remained consistent as day of gestation increased. Similar results were reported with the ovine 
model, in which peri-implantation conceptus GLUT3 mRNA was abundant and consistent from d 
12 to 20 of gestation (Gao et al., 2009a), and in the Holstein model, in which placental GLUT3 
mRNA was abundant and consistent from d 28 to 42 of gestation (Lucy et al., 2012). The known 
localization of GLUT3 in the ruminant placenta has been determined to be along the 
microvillous membrane in sheep and cattle (Wooding et al, 2005), and in the peri-implantation 
trophectoderm and extraembryonic endoderm of the ovine conceptus (Gao et al., 2009). 
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 Table 2.6 Glucose, arginine, ornithine, citrulline, and lysine concentrations in allantoic fluid, amniotic fluid and maternal 
plasma on d 40 and 50 of gestation. 
  
 Fluid1 
   
P - value2 
Nutrient3 
Day of 
Gestation4 
 Plasma Allantoic Amniotic 
Day 
Mean5  
SEM6 Day Fluid 
Day 
 × 
 Fluid 
Glucose 
 
  
  
 
 
0.2 0.05 < 0.01 0.10 
 
40  5.08 1.33 1.06 2.35g 
  
   
 
50  4.54 1.81 1.94 2.76h 
    
 
 Mean 
Fluid 
Mean7 4.59y 1.57x 1.50x      
 
Arginine 
 
  
  
 
 
58.4 0.03 < 0.01 < 0.01 
 
40  118.13a 578.41b 164.12a 286.89 
    
 
 
50  108.64a 237.97a 186.34a 177.64 
    
 
  
Fluid 
Mean 113.39 408.19 175.23      
 
Ornithine        36.4 0.95 < 0.01 0.51 
 40  76.15 154.05 62.35 97.52      
 50  64.71 153.11 76.51 98.11      
  
Fluid 
Mean 70.43b 153.58
a 69.43b      
 
Citrulline            
 40  73.71 12.54 Undetected 28.75  4.6 0.91 < 0.01 0.13 
 50  65.01 22.58 Undetected 29.19      
  
Fluid 
Mean 69.36a 17.56b Undetectedc      
 
Lysine 
 
  
  
 
 
39.9 0.80 < 0.01 0.31 
 
40  103.07 671.64 209.01 327.91 
    
 
  50  96.65 597.35 264.88 319.63           
  
Fluid 
Mean 99.86x 634.50z 236.95y       
6
2
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Table 2.6 Glucose, arginine, ornithine, citrulline, and lysine concentrations in allantoic fluid, amniotic fluid and maternal 
plasma on d 40 and 50 of gestation (continued). 
1Fluid = Concentrations of glucose (mM), arginine (µmol/L), ornithine (µmol/L), citrulline (µmol/L), and lysine (µmol/L) in 
maternal plasma, allantoic fluid, and amniotic fluid. 
2Probability values for the effect of day, fluid, and day × fluid on the concentration of glucose, arginine, ornithine, citrulline, and 
lysine in fluids.  
3Nutrient = Glucose, arginine, ornithine, citrulline, and lysine.  
4Day of Gestation = number of days after insemination.  
5Mean of nutrient concentration across fluid type within a given day of gestation. 
6SEM = The average SEM for day × tissue interaction was used for each item. d 40 n = 6, d 50 n = 5. 
7Mean of nutrient concentration across day of gestation within a given fluid type. 
a-bMeans within nutrient without a common superscript differ in day × fluid (P < 0.05). 
g-hMeans across fluid within day without a common superscript differ (P < 0.05). 
x-zMeans across day within fluid without a common superscript differ (P < 0.05). 
6
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Although GLUT1 and GLUT3 are both high affinity glucose transporters, (~5 mM and ~1.5mM 
respectively) GLUT3 transport capacity is the highest calculated of all the known GLUT 
isoforms, thus facilitating proportionally greater glucose uptake (Thorens and Mueckler, 2010). 
This is supported by Ganguly et al. (2007) who reported that a null mutation of GLUT3 resulted 
in early embryonic mortality in mice due to increased apoptosis in blastocysts. Data from Crouse 
et al. (2016) in bovine chorioallantois, found that GLUT3 expression was greater in pre-
implantation compared with post-implantation fetal membranes. Additionally, GLUT3 null mice 
failed to survive post implantation, even in nutrient rich growth mediums, due to failed 
neurulation (d ~ 8.5; Total gestation ~ 20 d; d 18-22 in bovine, Winters et al., 1942), or late-
gestation fetal growth restriction characterized by decreased GLUT3- mediated transplacental 
glucose transport (Ganguly et al., 2007).  
 Glucose is not the most abundant hexose sugar to be utilized by the fetus; rather it is 
fructose (Wang et al., 2016). Glucose is metabolized to fructose, however, by the placenta and 
stored in allantoic fluid (White et al 1979; Wu et al., 2004; Wang et al., 2016).  Glucose 
concentrations are at maximum 1.1 mM in ovine allantoic fluid whereas fructose can range from 
11.1 to 33.3 mM during gestation (Kim et al 2012). Even so, glucose is required for stimulation 
of the mammalian target of rapamycin (mTOR) by decreasing adenosine monophosphate-
activated protein kinase (AMPK; Tan and Miyamoto, 2016), as well as being coupled with 
fructose and glutamine activation of mTOR (Wang et al., 2016), and stimulating the abundance 
of the phosphorylated forms of the mTOR cell signaling pathway proteins, thereby decreasing 
autophagy and increasing protein synthesis. 
 Cationic amino acid transporters SLC7A1, SLC7A2, and SLC7A3 also known as the CAT 
transporters (CAT-1, CAT-2, and CAT-3) are part of the y+ system of transporters which are a 
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facilitated diffusion sodium-independent group of transporters known for transporting cationic 
amino acids such as arginine and lysine and at low pH, histidine (Closs et al.,2007). The three 
transporters studied vary in their stimulation and affinity; SLC7A1 exhibits KM values for L-
arginine, L-lysine of 100 – 150 µM, and is strongly stimulated by substrate on the trans-side of 
the membrane (Kim et al., 1991; Closs et al., 1997); SLC7A2 and SLC7A3 exhibit lower 
substrate affinity and are less dependent on trans-stimulation (Closs et al., 1997; Vekony et al., 
2001), with SLC7A2 having about a tenfold lower substrate affinity compared with SLC7A1 
(Closs et al., 1993; Kavanaugh et al., 1994; Closs et al., 1997). Knockout of SLC7A1 resulted in 
decreased arginine transport by 73%, arginine and its catabolites, citrulline and ornithine, by 
76% and 40% respectively, as well as decreased ODC1, NOS, and polyamines which resulted in 
retarded growth development of the conceptus (Wang et al., 2014).  
 In all three cationic amino acid transporters investigated (SLC7A1, SLC7A2, and 
SLC7A3), greater levels of mRNA expression were observed during key days of gestation; d 16 
at maternal recognition of pregnancy and implantation, and d 28 to 40 the critical window of 
placental development beyond which little embryonic/fetal loss occurs (Thatcher et al.,1994; 
Bridges et al., 2013). In ewes, mRNA of SLC7A1 and SLC7A2 increased through d 20 of 
gestation (Gao et al., 2009b). This is similar to what is reported in the current study in which 
SLC7A1 and SLC7A2 increased in expression through d 28 to 42. mRNA of SLC7A1 was 
determined to be most abundant in ovine uterine LE, sGE, and GE, and also in low abundance in 
conceptuses. mRNA of SLC7A2 was weakly expressed in trophectoderm and endoderm of 
conceptuses during peri-implantation in the ovine (Gao et al., 2009b). Additionally, P4 
stimulates expression of SLC7A1, but not IFN-τ, and that SLC7A2 is P4 induced as well as being 
IFN-τ stimulated (Gao et al., 2009b). Establishing the cellular localization of these transporters 
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as well as their influences by P4 and IFN-τ in cattle would provide additional insight into the 
function of these transporters in early gestation. In FM, SLC7A1 peaked in expression on d 34 
and 50, coinciding with increased expression on d 34 in maternal tissues. Concentration of 
arginine was greater on d 40 compared with d 50 of gestation, following a similar pattern as seen 
in maternal and fetal transporter expression, being greater d 34 of gestation and decreasing to d 
50.  
 Arginine is well known for its roles in angiogenesis and cellular proliferation as well as 
its actions on mTOR for protein synthesis and decreased protein degradation (Wang et al., 2016). 
When supplemented in diets of sheep, arginine increases embryonic and conceptus survival and 
growth rate (Wang et al., 2016), therefore suggesting that the amount of arginine transported into 
the uterine lumen and allantoic and amniotic fluids by nutrient transporters is vital to conceptus 
survival. Nitric Oxide (NO) is an important product of arginine catabolism, and plays a vital role 
in placental angiogenesis and exchange of nutrients and oxygen from maternal to fetal systems 
(Gouge et al 1998; Bird et al., 2003; Wang et al., 2014). Additionally, polyamines (produced 
from arginine catabolism) contribute to embryogenesis and placental development through their 
actions in DNA and protein synthesis, scavenging reactive oxygen species, cell proliferation, and 
differentiation of tissues (Wang et al., 2014). Supplemental lysine in the diet of rats reduced 
proteolysis and autophagy as well as upregulating the mTOR signaling pathway (Sato et al., 
2015). Additional information regarding the significance of lysine in fetal mTOR pathways was 
not found in ruminants; however, mean concentrations of lysine, were greater than that of 
arginine in our heifers, suggesting a role for lysine in conceptus viability. 
 Genes were greater in mean expression across all days in either CAR (GLUT3 and 
SLC7A3), ICAR (SLC7A1), or both CAR and ICAR (GLUT1 and SLC7A2) compared with FM 
  
67 
 
during the first 50 days of gestation. Although there was a general numerical increase in the 
expression of all transporters in FM; the overall expression of these transporters were never 
greater than the expression seen in either CAR or ICAR. Investigating specific cellular locations 
of these transporters using immunohistochemistry in future studies would provide greater insight 
into the functions of these transporters. Knowing temporal changes of transporters in endometrial 
and fetal tissues using immunohistochemistry, along with mRNA expression in utero-placental 
tissues, and nutrient concentrations in fluids would provide a more complete picture of 
establishment and function of transporters in utero-placental tissues. Ultimately, new knowledge 
in this area will facilitate the development of strategies to increase efficiencies associated with 
beef cattle production and contribute to meeting projected world food demands.   
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CHAPTER 3: RAPID COMMUNICATION: ISOLATION OF GLUCOSE 
TRANSPORTERS GLUT3 AND GLUT14 IN BOVINE UTERO-PLACENTAL TISSUES 
FROM DAYS 16 TO 50 OF GESTATION1 
Abstract 
 Glucose transporter GLUT14 is a duplicon of GLUT3 with a 95% shared homology to 
GLUT3, and has not previously been isolated in ruminant utero-placental tissues. The GLUT3 
transporter has been previously isolated in Holstein heifer uterine epithelium, but not in ovine 
epithelium. We hypothesized that GLUT3 and its duplicon GLUT14 would be found in bovine 
utero-placental tissues, and that maternal nutrition and day of gestation would impact mRNA 
expression of GLUT3 and GLUT14. Crossbred Angus heifers (n = 49) were estrus synchronized, 
bred via AI, and assigned to nutritional treatment (CON = 100% of requirements to gain 0.45 
kg/d; RES = 60% of CON) at breeding. Ovariohysterectomy was performed on d 16, 34, or 50 of 
gestation (n = 6 to 9/d); non-pregnant (NP) controls were not bred and ovariohysterectomized on 
d 16 of the synchronized estrous cycle (n = 6). The resulting treatment arrangement was a 2 × 3 
factorial + 1. Utero-placental tissues (caruncle, CAR; intercaruncular endometrium, ICAR; and 
fetal membrane [chorioallantois], FM) were obtained from the pregnant uterine horn 
immediately after ovariohysterectomy. For NP controls, only CAR and ICAR were obtained. 
There were no day × treatment interactions for GLUT3 or GLUT14 gene expression in CAR, 
ICAR, or FM. Expression of GLUT3 in CAR was greater (P = 0.03) on d 50 compared with d 16.  
1The material in this chapter was co-authored by M. S. Crouse, J. S. Caton, K. J. McLean, P. P. 
Borowicz, L. P. Reynolds, C. R. Dahlen, B. W. Neville, and A. K. Ward. It has been accepted for 
publication by the Journal of Animal Science, doi: 10.2527/jas.2016-0857. M. S. Crouse and K. 
J. McLean had primary responsibility for collecting samples. M. S. Crouse was the primary 
developer of the conclusions that are advanced here. M. S. Crouse also drafted and revised all 
versions of this chapter. A. K. Ward served as proofreader and checked the math in the statistical 
analysis conducted by M. S. Crouse 
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In ICAR, GLUT3 was greatest (P = 0.02) on d 50 compared with d 16 and 34 of gestation. In 
FM, GLUT3 was greater (P = 0.04) on d 16 compared with d 50. Expression of GLUT3 was 
greater (P = 0.05) in pregnant compared with non-pregnant heifers. Additionally expression of 
GLUT3 was greater (P = 0.01) on d 34 and 50 compared with d 16. Expression of GLUT14 in 
CAR was greater (P = 0.03) on d 50 compared to d 16 and 34. In CAR, GLUT14 tended (P = 
0.07) to be greater on d 34 and 50 compared with d 16, and was greater (P = 0.02) on d 50 
compared with d 34. There was no effect of treatment for either GLUT3 or GLUT14 in CAR, 
ICAR, or FM. These data demonstrate that glucose transporters GLUT3 and GLUT14 are 
expressed in beef heifer utero-placental tissues, and that they are expressed differentially by day 
of gestation in bovine utero-placental tissues. 
Key words: early gestation, facilitated transporters, glucose 
 
Introduction 
Glucose is a major source of energy for the conceptus during development, and acts as a 
regulator for cell proliferation and function through activation of the mammalian target of 
rapamycin (mTOR; Gao et al., 2009; Tan and Miyamoto, 2016). Glucose must be transported to 
the conceptus from the maternal system because neither conceptuses, nor uterine endometrium 
carry out gluconeogenesis (Gao et al., 2009). The most efficient known isoform of glucose 
transporter is GLUT3 (glucose transporter solute carrier family 2 member 3, also known as 
SLC2A3), which has highest transport capacity of any GLUT transporter, and is found in 
specific subcellular locations to ensure glucose transport (Ganguly et al., 2001).  The known 
localization of GLUT3 in the ruminant placenta has been determined to be along the 
microvillous membrane (Wooding et al, 2005). Known localization of GLUT3 in uterine tissue 
was established in the rat, in which GLUT3 was localized in both uterine stroma (dense 
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connective tissue), and uterine epithelium (Korgun et al., 2001). Specific uterine mRNA of 
GLUT3 in Holstein heifers was determined to be in the caruncular and intercaruncular epithelium 
(Lucy et al., 2012). The glucose transporter gene GLUT14 (glucose transporter solute carrier 
family 2 member 14, also known as SLC2A14), encodes a protein that is 497 amino acids in 
length, and shares 95% homology to GLUT3 (Wu and Freeze, 2002). The GLUT14 gene is 
considered a duplicon, as it may have arisen as a possible result of a duplication of GLUT3 (Wu 
and Freeze, 2002).  Contrary to GLUT3 however, GLUT14 has previously been specifically 
expressed in the testis, and was found to have expression levels four-fold greater than GLUT3 in 
testis. (Wu and Freeze, 2002).  Therefore, we tested the hypothesis that the mRNA for GLUT3 
and GLUT14 would be present in beef heifer utero-placental tissues, and would be differentially 
expressed due to day of gestation and maternal nutritional status. 
 
 Materials and Methods 
Protocols described herein were approved by the North Dakota State University 
Institutional animal care and use committee. 
Animals 
Crossbred Angus heifers (n = 49, ~15 mo of age; average initial BW = 324.9 kg) were 
exposed to the 5-d CO-Synch + CIDR (Eazi-Breed CIDR Cattle Insert, Nasko, Fort Atkinson, 
Wisconsin) estrus synchronization protocol. Six heifers were not inseminated to serve as non-
pregnant (NP) controls, but underwent ovariohysterectomy for tissue collections on d 16 of the 
synchronized estrous cycle. The remaining heifers (n = 6 to 9/d of gestation/treatment) were bred 
by AI bred to a common sire at 12 h after observed estrus and ovariohysterectomized at d 16, 34, 
or 50 of gestation (McLean et al., 2016). 
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Diet and Housing 
Heifers were housed at the North Dakota State University Animal Nutrition and 
Physiology Center. Heifers were acclimated to individual bunk feeding (American Calan, 
Northwood, NH) for two weeks before the beginning of the trial. Immediately following AI, 
heifers were randomly assigned to one of two treatment groups. Control heifers (CON) received 
100% of NRC (2000) requirements for 0.45 kg/d gain to reach 80% of mature BW at first 
calving. Restricted heifers (RES) were placed on a 40% global nutrient restriction which was 
accomplished by reducing total diet delivery to 60% of CON. The diet was delivered as a TMR 
(48.37% DM, 5.28% CP, 6.77% ash, and 29.43% NDF on a DM basis) of grass hay, corn silage, 
alfalfa haylage, and grain supplement. Dried distillers grains (87.5% DM, 8.2% ash, 31.3% CP, 
and 53.4% NDF on a DM basis) were supplemented on an individual basis to meet CON ADG, 
and restricted 40% for RES heifers.  
Sample Collection 
Immediately following ovariohysterectomy, utero-placental tissues (caruncle, CAR; 
intercaruncular endometrium, ICAR; fetal membrane [chorioallantois], FM) were obtained from 
the uterine horn containing the conceptus, as previously described (Grazul-Bilska et al., 2010, 
2011). Fetal membranes were collected only from pregnant heifers due to a lack of FM in NP 
controls. Once collected, all tissues were flash frozen in liquid nitrogen-cooled isopentane and 
stored at -80°C.  
Real-Time Quantitative PCR (qPCR) 
Total RNA was extracted and purified using Aurum Total RNA Mini Kit (Bio-Rad, 
Hercules, CA), and cDNA was synthesized utilizing iScript cDNA Synthesis Kit (Bio-Rad, 
Hercules, CA).  The RNA concentration was determined using Take3 module of a Synergy H1 
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Microplate Reader (BioTek, Winooski, VT). Gene expression was quantified using a 7500 Fast, 
Real-Time PCR System (Applied Biosystems, Grand Island, NY) with SYBR Green Master Mix 
(Bio-Rad Laboratories, Hercules, CA) in duplicate. Relative expression was calculated using the 
ΔΔCt method (Livak and Schmittgen, 2001) with β-Actin as a reference gene due to consistency 
of expression across day of gestation and utero-placental tissue type, compared with other 
reference genes investigated such as GAPDH, YWHAZ, TBP, and SDHA. The average of NP 
expression was used as the control within each tissue, with the exception of FM, in which NP 
endometrium sample was used as the control. 
Primer selection and validation 
Coding sequences for GLUT3 (Genbank accession number NM_174603.3) and GLUT14 
(Genbank accession number NC_007316.5) were aligned using CLUSTALW (EBI, 
Cambridgeshire, UK). The GLUT3 primer sequences were: forward- 
CAAGTCACAGTGCTAGAGTCTTTC, and reverse- GGAGAGCTGGAGCATGATAGAGAT 
(Mattmiller et al., 2011). The primers for GLUT14 were designed after alignment with GLUT3, 
and chosen based upon the area of greatest single nucleotide polymorphisms (SNP; bolded 
bases), forward- TATGCTTTGGAAAAGTGGTCAGGAACC, reverse- 
GATGGAGAAGGAACCGATCATA. Each primer pair was validated using 7500 Fast Real-
Time PCR system in CAR, ICAR, and FM from heifers on d 16, 34, and 50 of gestation to 
ensure product specificity. To confirm assay specificity, the end products of the qPCR reaction 
were sequenced. PCR products were purified using the Purelink Quick PCR Purification Kit 
(Invitrogen, Carlsbad, CA) and then sequenced using SimpleSeq (Eurofins MWG Operon LLC, 
Louisville, KY). Sequences from each tissue were aligned using MacVector version 14.5 
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(MacVector, Inc., Apex, NC) to ensure products were GLUT3 and GLUT14 respectively (Fig. 
3.1). 
Statistical Analysis 
Data were analyzed using the GLM procedure of SAS 9.3 (SAS Inst. Inc., Cary, NY) 
with day, treatment and day × treatment in the model. If no significant interactions were present, 
main effects of maternal nutrition and day of gestation were reported. Means were separated 
using LSMEANS, and P-values ≤ 0.05 were considered significant. Additionally, contrasts were 
conducted comparing the gene expression for NP vs. pregnant heifer, d 16 vs. d 34 and 50 (pre-
implantation vs. post-implantation), and d 34 vs. d 50 using the GLM procedure of SAS, with P-
values ≤ 0.05 being considered significant.  
 
Results 
GLUT3 
There was no day × treatment interaction for GLUT3 in CAR, ICAR, or FM. Expression 
of GLUT3 in CAR was greater (P = 0.03) on d 50 compared with d 16 (10.38 vs. 2.59 
respectively, SEM = 2.86; Table 3.1). In ICAR, GLUT3 was greatest (P = 0.02) on d 50 
compared with d 16 and 34 of gestation (3.20 vs. 1.96 and 1.14 respectively, SEM = 0.70; Table 
3.1). Conversely in FM, GLUT3 was greater (P = 0.04) on d 16 compared with d 50. Expression 
of GLUT3 in CAR was greater (P = 0.05) in pregnant heifers compared with NP controls. 
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800 810 820 830 840 850 860 870 880 890 
ANM_174603 CTCTGGGGCACCGAGGACGTGGCTCAGGATATCCAGGAGATGAAGGATGAGAGTATGCGGATGTCGCAGGAGAAGCAAGTCACAGTGCTAGAGCTCTTC 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Consensus: T.A..............T...........C........................G............G.........................-..... 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
NC_007316 T.A..............T...........C........................G............G....................C.......... 
GLUT3_R 
GLUT3_F ......................TC 
PC_R ..................-..... 
PIC ..................-..... 
NPIC ............-..... 
FMIC ....-..... 
PC_F 
NPC_F 
PIC_F 
NPIC_F 
FMC_F 
 
900 910 920 930 940 950 960 970 980 990 
NM_174603 GCGCCCCCAACTACCGGCAACCCATCATTATCTCTATCATGCTCCAGCTCTCCCAGCAGCTCTCTGGGATCAATGCAGTGTTCTACTACTCGACAGGAT 
Consensus: ...............................................................................A................... 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
NC_007316 .T...............A...........G....C.............................................A.................. 
GLUT3_R ........................ 
GLUT3_F 
PC_R ................-.. 
PIC_R ................-.. 
NPIC_R        ................-.. 
FMIC_R        ................c 
PC_F ..-.................................. 
NPC_F GGNA................................ 
PIC_F ..-................................ 
NPIC_F ............................... 
FMC_F ............................ 
   400        410      420       430       440      450       460  470 480        490  
BNC_007316             GATCATAAAGGACTTTCTCAATTATGCTTTGGAAAAGTGGTCAGGAACC-CCCCCGTCCAGCATGCTCCTCACATTCCTGTGGTCCTTGTCCGTGGCCAT 
                         ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Consensus:            .........A.......................................................................................... 
                   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
NM_174603               .........A..............CA........G..C.....-.....G............G............C...............T........ 
PC_F ..................................... 
PC_R .............................................N.................. 
PIC_F ..................................... 
PIC_R .......................................................................... 
NPC_F ..................................... 
NPIC_F ..................................... 
NPC_R .............................................................................. 
NPIC_R ............................................................................... 
FM_R ........................................T......A................... 
GLUT14F ........................... 
GLUT14_R 
     500 510 520 530 540 550 560 570 580 590 
NC_007316        CTTCTCCGTGGGTGGTATGATCGGTTCCTTCTCCATCGGACTCTTTGTCAACCGATTTGGCAGGCGCAATTCAATGTTTATTGTCAACCTGTTGGCCATA 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Consensus:                  ............................................................................C....................... 
       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
NM_174603        .....................T..C.........G.........................................C....................... 
PC_F                      ..................................... 
PC_R 
PIC_F              ..................................... 
PIC_R 
NPC_F              ..................................... 
NPIC_F              ..................................... 
NPC_R 
NPIC_R 
FM_R 
GLUT14F 
GLUT14_R                                     . . . . . . . . . . . . . . . . . . . . . . 
Figure 3.1 Primer validation with Sanger sequencing results. A. GLUT3 forward and reverse 
primers, along with validation in bovine utero-placental tissues. B. GLUT14 forward and 
reverse primers, along with validation in bovine utero-placental tissues. NM_174603- GLUT3 
coding sequence, NC_007316- GLUT14 coding sequence, PC- caruncles from the uterine 
horn containing the conceptus, PIC- intercaruncular tissue from the uterine horn containing 
the conceptus, NPC- caruncles from the uterine horn not containing the conceptus, NPIC- 
intercaruncular tissue from the uterine horn not containing the conceptus, FM- fetal 
membranes [chorioallantois], FMC- cotyledons from fetal membranes, FMIC- 
intercotyledonary fetal membrane. 
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Additionally expression of GLUT3 in CAR was greater (P = 0.01) on d 34 and 50 
compared with d 16. Glucose transporter GLUT3 tended (P = 0.08) to be greater in CON heifers 
in ICAR compared with RES heifers.  
GLUT14 
There was no day × treatment interaction for GLUT14 in CAR, ICAR, or FM. Expression 
of GLUT14 in CAR was greater (P < 0.05) on d 50 compared to d 16 and 34 (9.27 vs. 1.53 and 
2.65 respectively, SEM = 2.93; Table 3.1). In CAR, GLUT14 was greater (P = 0.02) on d 50 
compared with d 34 and tended (P = 0.07) to be greater on d 34 and 50 compared with d 16 
(Table 3.1). In ICAR, GLUT14 tended (P = 0.09) to be greater on d 16 compared with d 34 
(Table 3.1). There were no main effects of day of gestation or treatment in FM.  
 
Discussion 
This study is the first to confirm the presence of GLUT14 in bovine utero-placental 
tissues (using both qPCR and Sanger sequencing to ensure product specificity) on days 16, 34, 
and 50 of gestation. This study also validates previous data produced by Crouse et al. (2016) 
isolating GLUT3 expression in beef heifer utero-placental tissues on days 16, 22, 28, 34, 40, and 
50 of gestation.  
Glucose is a major source of energy for the conceptus and placenta during early gestation 
and is required for the maintenance of normal fetal metabolism and growth (Hay, 2006; Dunlap 
et al., 2015). Glucose must be transported into the uterine lumen and conceptuses via nutrient 
transporters in the endometrium and developing placenta. The main glucose transporters 
previously isolated in the ruminant uterus are GLUT1 (SLC2A1), GLUT4 (SLC2A4), SGLT1 
(SLC5A1), and SGLT11 (SLC5A11), of which GLUT1 and GLUT4 are sodium independent 
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glucose transporters and SGLT1 and SGLT11 are sodium dependent (Gao et al., 2009). In sheep, 
GLUT1 mRNA was most abundant in luminal epithelium and superficial glandular epithelium; 
In rats, GLUT3 was found to be in the uterine stoma and dense connective tissue; GLUT4 
mRNA was most abundant in luminal epithelium and glandular epithelium; SGLT1 mRNA was 
most abundant in luminal and glandular epithelium; and SGLT11 mRNA was most abundant in 
uterine glandular epithelium (Gao et al., 2009). The main glucose transporters of the ruminant 
placenta are GLUT1 and GLUT3 with GLUT4 (insulin dependent) and GLUT8 being less 
abundant (Zhang et al., 2015). The abundance of mRNA expressed for GLUT1 is found in the 
basal trophoblast membrane of the placenta (Hay, 2006): GLUT3 mRNA is more abundant in the 
microvillous membrane (Korgun et al., 2001); GLUT4 mRNA was determined to be more 
abundant in fibroblasts from amnion and chorion: and GLUT8 mRNA was found to be most 
abundant in the chorionic epithelial later (Zhang et al., 2015). 
The glucose transporters of interest in this study are the high affinity, high capacity 
GLUT3 and its duplicon, GLUT14. Glucose transporter GLUT3 is unique in comparison with 
other glucose transporters in utero-placental tissues in that a mutation of the GLUT3 gene in 
mice caused early embryonic mortality, indicating that the amount of glucose being transported 
by GLUT3 simply could not be made up for by other utero-placental glucose transporters 
including GLUT1, GLUT4, or GLUT8 (Ganguly et al., 2001). This is due to the transport 
capacity of GLUT3 at 1.5mM (Thorens and Mueckler, 2010) in comparison to GLUT1 at 6.9 
mM (Burant and Bell, 1992) and GLUT4 at 4mM (Nishimura et al., 1993) with the lower km 
equating to greater transport capacity. Additionally, isolating the presence of GLUT14 
expression in bovine utero-placental tissues indicates the uterine and placental need for another 
potentially high capacity glucose transporter. No research has been found determining the 
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transport capacity of GLUT14 to determine if it is comparable to GLUT3. However, like other 
GLUT transporters, GLUT14 contains 12 putative membrane-spanning helices along with sugar-
transporter signature motifs that have previously been shown to be essential for sugar transport 
activity (Wu and Freeze, 2002). This indicates that GLUT14 should be able to transport glucose, 
and establishment of its transport capacity would more greatly determine its role in glucose 
transport in the bovine utero-placenta. Additional work localizing the transporters using 
immunohistochemistry or RNA-fluorescent in situ hybridization would allow for determination 
of transporter location (e.g. caruncular or glandular). 
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Table 3.1 Fold change in gene expression of nutrient transporter GLUT3 and GLUT14 in caruncular and intercaruncular tissues due to 
dietary treatments from d 16 to 50 of gestation (Preg) relative to non-pregnant (NP) controls. 
    Day of Gestation1   P – values2 
Gene3 Tissue4 Trt5  16 34 50 Trt6 
SEM
7 
NP 
vs. 
Preg 
16 
vs. 
34 and 50 
34 
vs. 
50 
Day Trt 
Day × 
Trt 
GLUT3 CAR CON  3.60 6.40 10.07 6.69 2.86 0.05 0.01 0.13 0.03 0.85 0.87 
  RES  1.57 6.55 10.68 6.27        
   Day8 2.59b 6.47ab 10.38a         
GLUT3 ICAR CON  2.80 0.90 4.13 2.61 0.70 0.27 0.71 0.01 0.02 0.08 0.19 
  RES  1.13 1.39 2.27 1.60        
   Day 1.96b 1.14b 3.20a         
GLUT3 FM CON  0.63 0.30 0.36 0.42 0.15 - 0.02 0.36 0.04 0.12 0.33 
  RES  0.90 0.64 0.34 0.64        
   Day 0.78a 0.47ab 0.35b         
GLUT14 CAR CON  2.62 2.76 11.95 5.78 2.93 0.32 0.07 0.02 0.03 0.30 0.69 
  RES  0.44 2.55 6.60 3.20        
   Day 1.53b 2.65b 9.27a         
GLUT14 ICAR CON  6.74 2.48 4.78 4.66 1.50 0.27 0.36 0.29 0.09 0.33 0.55 
  RES  5.14 3.04 2.19 3.46        
   Day 5.94 2.76 3.48         
GLUT14 FM CON  0.60 0.79 1.51 0.97 0.83 - 0.74 0.38 0.62 0.76 0.94 
  RES  1.17 0.93 1.44 1.18        
   Day 0.88 1.86 1.48         
1 Number of days after insemination. 
2 Probability values for the effect of day, treatment, and day × treatment, as well as contrast statements comparing NP vs. Pregnant 
heifers, d 16 vs. d 34 and 50, and d 34 vs. 50 of gestation.  
3 GLUT3 = glucose transporter solute carrier family 2 member 3 (SLC2A3). GLUT14 = glucose transporter solute carrier family 2 member 
14 (SLC2A14). 
4 CAR = caruncles, ICAR = endometrium not including caruncles, FM = chorioallantois. 
5CON = heifers fed 100% of NRC requirements to gain 0.45 kg daily. RES = heifers fed 60% of CON diets achieved by reducing intake. 
6 Mean expression across day of gestation within gene and treatment. 
7 Average SEM was used within gene. 
8 Mean expression across treatment within gene and day of gestation. 
8
3
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It is of great interest that, even though GLUT14 arose as a duplication of GLUT3, the 
expression pattern between the two transporters differs. In CAR, both GLUT3 and GLUT14 
shared similar patterns of expression, increasing from d 16 to 50 of gestation. In ICAR, GLUT3 
transporter expression increased to d 50, while GLUT14 tended to be greater on d 16 of 
gestation. In FM, GLUT3 expression decreased to d 50 of gestation, while there was no effect of 
day of gestation for GLUT14. This is possibly indicative of differential transport capacity or 
preferential use of one transporter isoform over another. Specific expression of GLUT3 and 
GLUT14 in CAR demonstrates the establishment of a known high capacity transporter (GLUT3), 
and its duplicon, on the site of the placentome. Comparison of the overall expression of both 
transporters will need to be conducted in order to determine preferential use, and therefore 
further elucidate the functions of GLUT14 and GLUT3 in bovine utero-placental tissues.  
Glucose transporters are essential in tissues requiring high concentrations of glucose for 
energy due to their ability to transport glucose at a rate 10,000 times higher than passive 
diffusion across the lipid bilayer of the cell (Elbrink and Bihler, 1975). Although fructose, not 
glucose, is the main hexose found in fetal fluids (Kim et al., 2012), glucose is essential for use by 
trophoblast as an energy source for energy-dependent active amino acid transporters (Hay, 
2006). Additionally, the placenta metabolizes glucose to fructose via the aldose reductase 
pathway thereby supplying fructose as the main hexose sugar to the developing embryo 
(Meznarich et al., 1987).  
The protein kinase mTOR is responsible for regulating cell growth and proliferation or 
autophagy and is directly activated by nutrient (glucose) presence, and inactivated when 
nutrients are not present (Tan and Miyamoto, 2016; Wang et al., 2016). In the conceptus, glucose 
activates mTOR through the conversion of glucose-6-phosphate to fructose-6-phosphate, then 
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metabolism by glutamine-fructophosphate transamidase 1 (GFPT-1). Metabolism by GFPT-1 
activates the mTOR signaling cascade, which increases cellular proliferation and autophagy 
during critical time windows such as implantation and maternal recognition of pregnancy (Wang 
et al., 2016). Therefore, it is of utmost importance for glucose to be present in the uterine 
environment and readily available for the conceptus to utilize for activation of mTOR in a 
concerted effort to increase conceptus proliferation and growth. 
In conclusion, this data supports our hypothesis that GLUT3 and GLUT14 are present in 
beef heifer utero-placental tissues from days 16 to 50. Additionally, GLUT3 was differentially 
expressed in all tissues and GLUT14 in CAR from d 16 to 50 of gestation. No effect of 
nutritional treatment was found on GLUT3 or GLUT14 expression. These data have established 
the presence of GLUT3 in beef heifer utero-placental tissues, and are the first to isolate GLUT14 
in ruminant utero-placental tissue. Further research should be conducted to determine the exact 
cellular location of GLUT14 in utero-placental tissues, as well as determine its substrate 
preferences and affinities. This would better define the role that GLUT14 plays in supplying 
glucose for the establishment and maintenance of pregnancy. 
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CHAPTER 4: MATERNAL NUTRITION AND STAGE OF EARLY PREGNANCY IN 
BEEF HEIFERS: IMPACTS ON EXPRESSION OF GLUCOSE, FRUCTOSE, AND 
CATIONIC AMINO ACID TRANSPORTERS 
Abstract 
We hypothesized that maternal nutrition and day of gestation would impact mRNA 
expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in beef heifers. 
Crossbred Angus heifers (n = 49; 16 mo of age; BW=325 kg) were estrus synchronized, bred via 
AI, assigned to nutritional treatment (CON = 100% of requirements for 0.45 kg/d gain and RES 
= 60% of CON) and ovariohysterectomized on d 16, 34, or 50 of gestation (n = 6 to 9/d); non-
pregnant (NP) controls were not bred and ovariohysterectomized on d 16 of the synchronized 
estrous cycle (n = 6). Caruncle (CAR), intercaruncular endometrium (ICAR), and fetal 
membranes (FM), were obtained from the pregnant uterine horn. For NP controls, only CAR and 
ICAR were obtained. Relative expression of the glucose transporter GLUT1, fructose transporter 
GLUT5 and cationic amino acid transporters CAT-1, CAT-2, and CAT-3 was determined for each 
tissue utilizing NP-CAR and NP-ICAR tissue as the baseline. For FM, average of NP CAR and 
ICAR served as the baseline. There was no day × treatment interaction in CAR for any genes (P 
≥ 0.05). Expression of GLUT1 was greater (P < 0.01) on d 16 compared with d 34 and 50, and 
GLUT5, CAT-1, and CAT-2 were greater (P ≤ 0.05) on d 34 compared with d 16 and 50. 
Expression of CAT-2 in ICAR was the only gene in any tissue to be influenced by a day × 
treatment interaction (P = 0.01) being greater in d 50 CON, compared with d 16 and 50 RES, and 
d 34 CON. Expression of GLUT1 in ICAR was greater (P < 0.01) on d 16 compared with d 34, 
and CAT-1 was greater (P < 0.01) on d 34 and 50 compared with d 16 in ICAR. There was no 
day × treatment interaction in FM for any genes (P ≥ 0.05). Expression of GLUT5 was greater (P 
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= 0.04) on d 16 compared with d 50 of gestation, and CAT-1 in FM was greater (P < 0.01) on d 
34 and 50 compared with d 16. There was no treatment × tissue interaction for GLUT1, GLUT3, 
GLUT5, GLUT14, CAT-1, CAT-2, or CAT-3. In the days and tissues investigated, GLUT1 was 
influenced by a day × tissue interaction, being greater (P < 0.01) in d 16 CAR, GLUT3 was 
greater (P = 0.02) in d 50 CAR, GLUT5 was greater (P < 0.01) in d 34 CAR and 16 FM, and 
CAT-1 was greater (P < 0.01) in d 34 ICAR. These results partially support our hypothesis that 
nutrition and day of gestation would alter gene expression, and indicate that day was a more 
influential factor for mRNA expression of utero-placental glucose and cationic amino acid 
transporters than maternal nutritional status in heifers during early pregnancy. 
Key Words: beef heifers, gestation, nutrient transporters, maternal nutrition 
 
Introduction 
Fetal growth is vulnerable to maternal dietary nutrient deficiencies during the 1st trimester 
of gestation (Wu et al., 2004). The first 50 days of gestation is a critical developmental window 
in which significant cellular and tissue differentiation and major organogenesis occurs. 
Nutritional influences may alter the mammalian phenotype through affecting gene regulatory 
mechanisms involved in DNA synthesis and replication, thus “imprinting” potential 
susceptibilities to chronic disease and metabolic issues into the genome (Waterland and Jirtle, 
2004). Currently, fetal undernutrition occurs in grazing livestock worldwide (Wu et al., 2004). 
Maternal undernutrition has been implicated in fetal growth restriction and altered placental 
growth, reduced amino acid and glucose transport, and increased apoptosis and autophagy, 
which overall can yield decreased fetal growth during gestation (Zhang et al., 2015). Before the 
establishment of hemotrophic nutrition, the placenta is developing and the conceptus begins to 
  
91 
 
utilize increasing quantities of glucose and amino acids supplied by histotroph (Groebner et al., 
2011). Thus, the expression of glucose and amino acid transporters in the utero-placenta 
becomes essential to the viability of the conceptus. Therefore, we studied the utero-placental 
glucose transporters GLUT1, GLUT3, and GLUT14 (SLC2A1, 3, and 14), which are all sodium-
independent facilitated diffusion glucose transporters, and GLUT5 (SLC2A5) which is a sodium-
independent facilitated diffusion fructose transporter. We also investigated the cationic amino 
acid transporters CAT-1, CAT-2 and CAT-3 (SLC7A1, 2, and 3), which are all sodium-
independent facilitated diffusion arginine and lysine transporters. In this experiment, we tested 
the hypothesis that mRNA for glucose and cationic amino acid transporters in utero-placental 
tissues would be differentially expressed due to day of gestation and maternal nutritional status. 
 
Materials and Methods 
All animal procedures were approved by the North Dakota State University Institutional 
Animal Care and Use Committee (#A14053 and Al6049). 
Animals, Housing and Diet   
Crossbred Angus heifers were obtained from the Central Grasslands Research and 
Extension Center (Streeter, ND; 229 km southwest of Fargo; n = 49, ~16 mo of age; average 
initial BW = 325 ± 12.5 kg) and housed at the North Dakota State University Animal Nutrition 
and Physiology Center. Heifers were acclimated to individual bunk feeding (American Calan, 
Northwood, NH) for two weeks before the beginning of the trial. All heifers were exposed to the 
5-d CO-Synch + CIDR estrus synchronization protocol (Bridges et al., 2008). Six heifers were 
not inseminated to serve as non-pregnant (NP) controls, but received ovariohysterectomy for 
tissue collections on d 16 of the synchronized estrous cycle. The remaining heifers were bred by 
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AI bred to a common sire at 12 h after observed estrus, and were randomly assigned to one of 
two treatment groups. Control heifers (CON), received 100% of NRC (2000) requirements for 
0.45 kg/d gain to reach 80% of mature BW at first calving. Restricted heifers (RES), were placed 
on a 40% global nutrient restriction which was accomplished by reducing total diet delivery to 
60% of the control delivery. The diet was delivered via TMR (48.37% DM, 5.28% CP, 6.77% 
ash, and 29.43% NDF on a DM basis) and consisted of grass hay, corn silage, alfalfa haylage, 
grain and mineral mix, and supplemented dried distillers grains with solubles (DDG; 53.4% 
NDF, 31.3% CP) to meet individual heifers protein requirements. All treated heifers were 
ovariohysterectomized on either d 16 (CON, n = 7; RES, n = 7), 34 (CON, n = 6; RES, n = 9), or 
50 (CON, n = 7; RES, n = 7) of gestation. Thus, experimental design for the pregnancy analysis 
was a 2 × 3 factorial +1 design. 
Sample Collection and Analysis 
Ovariohysterectomy procedures were conducted as described by McLean et al. (2016). 
Immediately following ovariohysterectomy, utero-placental tissues (caruncle, CAR; 
intercaruncular endometrium, ICAR; fetal membranes, FM [chorioallantois, d 16 and 34]; 
cotyledonary placenta COT [d 50 only]; intercotyledonary placenta, ICOT [d 50 only]; and 
amnion, AMN [d 50 only]) were obtained from the uterine horn ipsilateral to the Corpus 
Luteum, which was also the horn containing the conceptus when observable, as previously 
describe (Grazul-Bilska et al., 2010, 2011). Once collected, all tissues were snap-frozen in liquid 
nitrogen cooled isopentane (2-Methylbutane; J.T.Baker, center Valley, PA) and stored at -80°C. 
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Table 4.1. Primer sets used for real-time quantitative reverse-transcription PCR1 
Gene1 Forward primer (5'-3') Reverse Primer (5'-3') Accession No. 
GLUT1 CGGCTGCCCTGGATGTC GCCTGGGCCCACTTCAAA NM_174602 
GLUT3 CAAGTCACAGTGCTAGAGTCTTTC GGAGAGCTGGAGCATGATAGAGAT NM_174603 
GLUT5 AGTCTCCTGGCAAACGAAGA AAGAAGGGCAGGAAGAGGAG NM_001101042.2 
GLUT14 TATGCTTTGGAAAAGTGGTCAGGAACC GATGGAGAAGGAACCGATCATA NC_007316.5 
CAT-1 CCGATAATCGCCACCTTAACCT ACCAGGTCCTTCAGGTCGAA DQ399522 
CAT-2 CTGCAAGTGCCAGGGACCCAC GGTTGCAGCCCCAGCCAAAGT XM_865568.3 
CAT-3 GTAGCCCCAACCCAACTCGGC TGCTAGGAAGGATCGAGGAGCTGT NM_001078019.1 
β-Actin TGTCCACCTTCCAGCAGATGT AGCTCAGTAACAGTCCGCCTAGA AB098974.1 
1GLUT1, GLUT3, and GLUT14- Glucose transporter solute carrier family 2 member 1. GLUT5- Fructose transporter solute 
carrier family 2 member 5. CAT-1, CAT-2, and CAT-3- Cationic amino acid transporters of arginine and lysine, solute 
carrier family 7 member 1, 2, and 3. B-Actin- Reference gene used in all tissues to complete ΔΔ Ct method. 
9
3
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Real-time quantitative PCR (qPCR) was done on CAR, ICAR, and FM samples to 
determine mRNA expression of glucose transporter 1 (GLUT1- facilitative diffusion glucose 
transporter which is found in most tissues throughout the body and is ubiquitous across 
mammalian species), glucose transporter 3 (GLUT3- facilitative diffusion high capacity glucose 
transporter known for neural and placental glucose transport), fructose transporter (GLUT5- 
facilitative diffusion fructose transporter) glucose transporter 14 (GLUT14- duplicon of GLUT3 
bearing 95% homology previously isolated in testis and bovine utero-placental tissues), and 
cationic amino acid transport 1, 2, and 3 (CAT-1, CAT-2, and CAT-3- all of which are facilitated 
diffusion arginine and lysine transporters). The RNA was extracted and purified using Aurum 
Total RNA Mini Kit (Bio-Rad, Hercules, CA), and cDNA was synthesized utilizing iScript 
cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Concentration of RNA was determined using 
Take3 module of a Synergy H1 Microplate Reader (BioTek, Winooski, VT). Optimal cDNA 
dilutions were determined by primer validation for each gene and tissue type across days of 
gestation. Primers (Table 4.1) were obtained from Integrated DNA Technologies (Coralville, IA) 
and used at a final concentration of 500 nM per reaction. Gene expression was quantified in 
duplicate using a 7500 Fast, Real-Time PCR System (Applied Biosystems, Grand Island, NY) 
with SYBR Green Master Mix (Bio-Rad Laboratories, Hercules, CA). Relative expression was 
calculated using the ΔΔCt method (Livak and Schmittgen, 2001) with β-Actin as a reference 
gene due to consistency of expression across day of gestation and utero-placental tissue type, 
compared with other reference genes investigated such as GAPDH, YWHAZ, TBP, and SDHA. 
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Statistical Analysis 
 Day × Treatment.   
On d 50, COT and ICOT mRNA level of expression were averaged within heifer to yield 
the FM value to complete the 2 × 3 factorial arrangement. For CAR, ICAR, and FM, data were 
analyzed using the GLM procedure of SAS (SAS Inst. Inc.) with day, treatment and day × 
treatment in the model, with individual heifer serving as the experimental unit. NP CAR, ICAR, 
and an average NP CAR and ICAR samples served as the baseline of expression set to 1 for 
CAR, ICAR, and FM level of expression, respectively. If no significant interactions were 
present, main effects of maternal nutrition and day of gestation were reported. Means were 
separated using the LSMEANS procedure of SAS, and P-values ≤ 0.05 were considered 
significant. Additionally, if no significant interactions were present, contrasts were conducted 
incorporating the NP heifers comparing the mRNA expression for NP vs. pregnant heifers, as 
well as d 16 vs. d 34 and 50 (pre-attachment vs. post-attachment), and day post-attachment 
comparison (d 34 vs. 50) for each individual gene using the GLM procedure of SAS, with P-
values ≤ 0.05 being considered different.  
 Day × Tissue and Tissue × Treatment.   
In order to evaluate the level of expression of glucose, fructose, and cationic amino acid 
transporters between CAR, ICAR, and FM from d 16 to 50 of gestation, data were analyzed for 
an interaction between day of gestation and utero-placental tissue type, as well as utero-placental 
tissue type and maternal nutritional treatment using the GLM procedure of SAS 9.3 (SAS Inst. 
Inc.) with individual heifer serving as the experimental unit. The NP endometrium served as the 
baseline of expression of 1 within each gene. If no significant interaction was present, main 
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effect of tissue was analyzed within each individual gene of interest using the GLM procedure of 
SAS 9.3 (SAS Inst. Inc.).  
Day 50 Fetal Tissue Comparison.   
For COT, ICOT, and AMN on d 50, a tissue × treatment analysis was conducted using 
the GLM procedure of SAS 9.3 (SAS Inst. Inc. Cary, NY) with tissue, treatment, and tissue × 
treatment in the model, and individual heifer serving as the experimental unit. In the absence of 
an interaction, main effects of tissue and treatment were analyzed within each individual gene of 
interest using the GLM procedure of SAS 9.3) (SAS Inst. Inc.), with the NP endometrium 
serving as the baseline of expression set to 1 for each gene. Means for all analysis discussed 
previously were separated with the LSMEANS procedure of SAS 9.3 (SAS Inst. Inc.) and P – 
values ≤ 0.05 were considered different. 
 
Results 
Day × Treatment 
CAR 
 Expression of glucose transporter GLUT1 was not influence by a day × treatment 
interaction (P = 0.23; Table 4.2) and was greater (P < 0.01) on d 16 (2.89-fold) compared with d 
34 and 50 (0.85 and 1.14-fold; SEM 0.31; Table 4.2). There was no day × treatment interaction 
for GLUT3 in CAR (P = 0.87) and was greater (P = 0.03) on d 50 compared with d 16 (10.38 vs. 
2.59 respectively, SEM = 2.86; Table 4.2). Expression of GLUT3 in CAR (data previously 
published and presented here for completeness of data presentation; Crouse et al., 2016) was 
greater (P = 0.05) in pregnant heifers compared with NP controls.   
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  Table 4.2 mRNA level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in caruncular (CAR) 
tissue due to CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1. 
   Day of Gestation2  P - values3 
Gene1 Trt4  16 34 50 Trt5 SEM6 
NP 
vs. 
Preg 
16 
vs. 
34 + 50 
34 
vs. 
50 
Day Trt 
Day 
× 
Trt 
GLUT1 CON  2.40 0.93 1.38 1.57 0.44 0.21 < 0.01 0.47 < 0.01 0.77 0.23 
RES  3.38 0.76 0.89 1.67 
 
  
  
  
 
 
Day7 2.89g 0.85h 1.14h  
 
  
  
  
GLUT38 CON  3.60 6.40 10.07 6.69 2.86 0.05 0.01 0.13 0.03 0.85 0.87 
RES  1.57 6.55 10.68 6.27        
  Day 2.59b 6.47ab 10.38a         
GLUT5 CON  6.61 22.05 9.07 12.58 15.33 0.24 0.06 < 0.01 0.02 0.35 0.20 
RES  2.97 66.74 3.91 24.54        
  Day 4.79h 44.40g 6.49h         
GLUT149 CON  2.62 2.76 11.95 5.78 2.93 0.32 0.07 0.02 0.03 0.30 0.69 
RES  0.44 2.55 6.60 3.20        
  Day 1.53b 2.65b 9.27a         
CAT-1 CON  1.08 5.24 0.53 2.28 1.03 0.21 0.09 < 0.01 < 0.01 0.78 0.90 
RES  1.85 5.20 0.49 2.51 
 
  
  
  
  Day 1.47h 5.22g 0.51h       
CAT-2 CON  5.76 14.37 7.98 9.37 3.63 0.06 0.02 0.04 0.02 0.77 0.89 
RES  2.95 14.97 7.58 8.50        
  Day 4.36h 14.67g 7.78gh         
CAT-3 CON  1.29 2.23 4.28 2.60 1.09 0.44 0.24 0.11 0.20 0.06 0.90 
RES  0.45 0.99 2.05 1.16        
  Day 0.87 1.61 3.16         
9
7
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Table 4.2 Level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in caruncular (CAR) tissue due 
to CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1 (continued). 
1Gene = GLUT1- Glucose transporter solute carrier family 2 member 1.GLUT5- Fructose transporter solute carrier family 2 
member 5. CAT-1, CAT-2, and 
CAT-3 - Cationic amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3. 
2Day of Gestation = number of days after insemination. Each gene expression is given as a fold change in relation to NP level of 
expression set to 1. 
3Probability values for effect of d, treatment, and day × treatment on level of expression of individual genes. Probability values for 
the contrast of mRNA 
level of expression of NP vs. Preg (all days of gestation), d 16 of gestation vs. d 34 and 50 of gestation, and d 34 vs. d 50 of 
gestation.  
4CON = Heifers fed a diet that meets 100% of NRC requirements to gain 0.45 kg daily. RES =  Heifers restricted to 60% of CON 
diet 
5Mean level of expression of treatment group across day of gestation within tissue and gene of interest. 
7Mean level of expression across treatment within day and gene of interest. 
8Previously published data (Crouse et al., 2016a). 
9Previously published data (Crouse et al., 2016a). 
a-cMeans within gene and tissue without a common superscript differ in day × treatment (P ≤ 0.05). 
g-hMeans within row without a common superscript differ in main effect of day (P ≤ 0.05). 
9
8
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Additionally, GLUT3 was greater (P = 0.01) on d 34 and 50 compared with d 16. 
Fructose transporter GLUT5 expression was not influenced by a day × treatment interaction (P = 
0.20) and was greater (P = 0.02) on d 34 (44.4-fold) of gestation compared with d 16 and 50 
(4.79 and 6.49-fold; SEM = 10.9; Table 4.2). Additionally, GLUT5 tended (P = 0.06) to be 
greater in expression on d post-attachment (34 + 50) compared with d pre-attachment (d 16; 
Table 4.2). Expression of GLUT14 (Crouse et al., 2016) was not influenced by a day × treatment 
interaction in CAR (P = 0.69) and was greater (P < 0.05) on d 50 compared to d 16 and 34 (9.27 
vs. 1.53 and 2.65 respectively, SEM = 2.93; Table 4.6). As well, GLUT14 was greater (P = 0.02) 
on d 50 compared with d 34 and tended (P = 0.07) to be greater on d 34 and 50 compared with d 
16 (Table 6). A day × treatment interaction did not influence the mRNA expression of CAT-1 in 
CAR (P = 0.90). However, CAT-1 was greater (P < 0.01) on d 34 (5.22-fold) compared with d 16 
and 50 (1.47 and 0.51-fold; SEM = 0.73; Table 4.2). Additionally, expression of CAT-1 tended 
(P = 0.09) to be greater in expression on days post-attachment compared with day pre-
attachment (Table 4.3). Expression of CAT-2 in CAR was not influenced by a day × treatment 
interaction (P = 0.89), but was greater (P = 0.02) on d 34 (14.67-fold) compared with d 16 (4.36-
fold; SEM = 2.55) with d 50 (7.78-fold) being not different from both d 16 and 34 of gestation 
(Table 4.2). Expression of CAT-2 tended (P = 0.06) to be greater in pregnant heifers compared 
with non-pregnant heifers. Additionally, CAT-2 expression was greater (P = 0.02) post-
attachment compared with pre-attachment (Table 4.2). Expression of cationic amino acid 
transporter CAT-3 was not influenced by a day × treatment interaction (P = 0.90) andCAT-3 
tended (P = 0.06) to be greater in expression in CON treated heifers compared to the RES treated 
heifers across all days of gestation (2.60 and 1.16-fold greater than NP; SEM = 0.64; Table 4.2). 
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Table 4.3 Level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in intercaruncular ICAR tissue due to 
CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1. 
   Day of Gestation2  P - values3 
Gene1 Trt4  16 34 50 Trt5 SEM6 
NP 
vs. 
Preg 
16 
vs. 
34 + 50 
34 
vs. 
50 
Day Trt 
Day 
× 
Trt 
GLUT1 
 
CON  2.44 0.63 1.77 1.61 0.39 0.43 < 0.01 0.10 < 0.01 0.26 0.42 
RES  1.77 0.87 1.08 1.24 
 
  
  
  
 
 
Day7 2.11g 0.75h 1.43gh  
 
  
  
  
GLUT38 CON  2.80 0.90 4.13 2.61 0.70 0.27 0.71 0.01 0.02 0.08 0.19 
RES  1.13 1.39 2.27 1.60        
  Day 1.96b 1.14b 3.20a         
GLUT5 CON  1.45 3.60 6.11 3.72 3.30 0.36 0.58 0.97 0.85 0.66 0.31 
RES  3.59 3.82 1.20 2.87        
  Day 2.52 3.71 3.66         
GLUT14
9 
CON  6.74 2.48 4.78 4.66 1.50 0.27 0.36 0.29 0.09 0.33 0.55 
RES  5.14 3.04 2.19 3.46        
  Day 5.94 2.76 3.48         
CAT-1 
 
CON  0.65 13.86 9.94 8.15 2.59 < 0.01 < 0.01 0.13 < 0.01 0.56 0.89 
RES  0.51 15.37 12.33 9.41 
 
  
  
  
  Day 0.58h 14.62g 11.13g       
CAT-2 
 
CON  6.83ab 2.31c 7.78a 5.64 1.43 - - - 0.22 0.68 0.01 
RES  3.10bc 6.08abc 3.17bc 4.11        
  Day 4.97 4.19 5.48         
CAT-3 
 
CON  9.69 1.55 5.53 5.59 1.89 0.09 0.12 0.27 0.13 0.45 0.09 
RES  3.87 4.25 5.05 4.39        
  Day 6.78 2.90 5.29         
1
0
0
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Table 4.3 Level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in intercaruncular ICAR tissue due to 
CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1 (continued). 
1Gene = GLUT1- Glucose transporter solute carrier family 2 member 1. GLUT5- Fructose transporter solute carrier family 2 member 5. 
CAT-1, CAT-2, and CAT-3 - Cationic amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3. 
2Day of Gestation = number of days after insemination. Each gene expression is given as a fold change in relation to NP level of 
expression set to 1. 
3Probability values for effect of day, treatment, and day × treatment on level of expression of individual genes. Probability values for the 
contrast of mRNA level of expression of NP vs. Preg (all days of gestation), d 16 of gestation vs. d 34 and 50 of gestation, and d 34 vs. d 
50 of gestation.  
4CON = Heifers fed a diet that meets 100% of NRC requirements to gain 0.45 kg daily. RES =  Heifers restricted to 60% of CON diet 
5Mean level of expression of treatment group across day of gestation within tissue and gene of interest. 
6Average SEM was used within gene. NP n = 6, d 16 CON n = 7, d 16 RES n = 7, d 34 CON n = 6, d 34 RES n = 9, d 50 CON n = 7, d 50 
RES n = 7 
7Mean level of expression across treatment within day and gene of interest. 
8Previously published data (Crouse et al., 2016a). 
9Previously published data (Crouse et al., 2016a). 
a-cMeans within gene and tissue without a common superscript differ in day × treatment (P ≤ 0.05). 
g-hMeans within row without a common superscript differ in main effect of day (P ≤ 0.05). 
1
0
1
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ICAR  
Expression of GLUT1 in ICAR was not influenced by a day × treatment interaction (P = 
0.42) and was greater on d 16 (2.11-fold) compared with d 34 (0.75-fold greater than NP; SEM = 
0.28; Table 4.3). Additionally, GLUT1 expression was greater (P < 0.01) in expression pre-
attachment compared with post-attachment, as well as tending (P = 0.10) to be greater on d 50 
compared with d 34 (Table 4.3). Expression of GLUT3 in ICAR (Crouse et al., 2016) was not 
influenced by a day × treatment interaction (P = 0.19) and was greatest (P = 0.02) on d 50 
compared with d 16 and 34 of gestation (3.20 vs. 1.96 and 1.14 respectively, SEM = 0.70; Table 
4.3). Glucose transporter GLUT3 tended (P = 0.08) to be greater in CON heifers in ICAR 
compared with RES heifers.  Fructose transporter GLUT5 was not influenced by a day × 
treatment interaction, or a main effect of day or treatment (P ≥ 0.05; Table 4.3). In ICAR, 
GLUT14 (Crouse et al., 2016) was not influenced by a day × treatment interaction (P = 0.55) and 
tended (P = 0.09) to be greater on d 16 compared with d 34 (Table 4.3). Expression of CAT-1 
was not influenced by a day × treatment (P = 0.89) and was greater (P < 0.01) on d 34 and 50 
(14.62 and 11.13-fold, respectively) compared with d 16 (0.58-fold, respectively; SEM = 1.84; 
Table 4.3). Additionally, average expression of pregnant heifers across all days of gestation was 
greater (P < 0.01) than non-pregnant. Expression of CAT-2 was influenced by a day × treatment 
interaction, being greater (P = 0.01) on d 50 CON (7.78-fold) compared with d 16 and 50 RES 
and d 34 CON (3.10, 3.17, and 2.31-fold, respectively; SEM = 1.43; Table 4.3). Additionally, d 
16 CON (6.83-fold) was intermediate and greater (P < 0.05) compared with d 34 CON (2.31-
fold, respectively; SEM = 1.43; Table 4.3). Expression of CAT-3 tended (P = 0.09) to be 
influenced by a day × treatment interaction (Table 4.3).  
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Table 4.4 Level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in fetal membrane FM tissue due to 
CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1. 
   
Day of 
Gestation2 
 P - values3 
Gene1 Trt4  16 34 50 Trt5 SEM6 
NP 
vs. 
Preg 
16 
vs. 
34 + 50 
34 
vs. 
50 
Day Trt 
Day 
× 
Trt 
GLUT1 
 
CON  0.11 0.26 0.26 0.21 0.08 - 0.14 0.94 0.35 0.61 0.90 
RES  0.19 0.27 0.27 0.24 
 
  
  
  
 
 
Day
7 0.15 0.26 0.27  
 
  
  
  
GLUT38 CON  0.63 0.30 0.36 0.42 0.15 - 0.02 0.36 0.04 0.12 0.33 
 RES  0.90 0.64 0.34 0.64        
  Day 0.78a 0.47ab 0.35b         
GLUT5 CON  59.78 43.59 33.40 45.59 19.54 - 0.01 0.12 0.04 0.52 0.44 
 RES  100.57 46.63 21.38 56.19        
  Day 80.17g 45.11gh 27.39h         
GLUT149 CON  0.60 0.79 1.51 0.97 0.83 - 0.74 0.38 0.62 0.76 0.94 
 RES  1.17 0.93 1.44 1.18        
  Day 0.88 1.86 1.48         
CAT-1 
 
CON  0.04 0.22 0.19 0.15 0.04 - < 0.01 0.24 < 0.01 0.67 0.99 
RES  0.05 0.24 0.20 0.16 
 
  
  
  
  Day 0.05h 0.23g 0.19g       
CAT-2 
 
CON  0.42 0.84 1.01 0.76 0.28 - 0.04 0.55 0.10 0.82 0.47 
RES  0.24 1.16 0.72 0.70        
  Day 0.33 1.00 0.86         
CAT-3 
 
CON  0.08 1.33 1.32 0.91 1.37 - 0.84 0.47 0.76 0.30 0.52 
RES  2.38 0.93 2.20 1.84        
  Day 1.23 1.13 1.76         
1
0
3
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Table 4.4 Level of expression of nutrient transporters GLUT1, GLUT5, CAT-1, CAT-2, and CAT-3 in fetal membrane FM tissue due to 
CON and RES dietary treatments from d 16 to 50 of gestation and in non-pregnant (NP) controls set to 1 (continued). 
1Gene = GLUT1- Glucose transporter solute carrier family 2 member 1.  GLUT5- Fructose transporter solute carrier family 2 member 5. 
CAT-1, CAT-2, and CAT-3 - Cationic amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3. 
2Day of Gestation = number of days after insemination. Each gene expression is given as a fold change in relation to NP level of 
expression set to 1. 
3Probability values for effect of d, treatment, and day × treatment on level of expression of individual genes. Probability values for the 
contrast of mRNA level of expression of NP vs. Preg (all days of gestation), d 16 of gestation vs. d 34 and 50 of gestation, and d 34 vs. d 
50 of gestation.  
4CON = Heifers fed a diet that meets 100% of NRC requirements to gain 0.45 kg daily. RES =  Heifers restricted to 60% of CON diet 
5Mean level of expression of treatment group across day of gestation within tissue and gene of interest. 
6Average SEM was used within gene. NP n = 6, d 16 CON n = 7, d 16 RES n = 7, d 34 CON n = 6, d 34 RES n = 9, d 50 CON n = 7, d 50 
RES n = 7 
7Mean level of expression across treatment within day and gene of interest. 
8Previously published data (Crouse et al., 2016a). 
9Previously published data (Crouse et al., 2016a). 
a-cMeans within gene and tissue without a common superscript differ in day × treatment (P ≤ 0.05). 
g-hMeans within row without a common superscript differ in main effect of day (P ≤ 0.05). 
1
0
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FM 
 Glucose transporter GLUT1 was not influenced by a day × treatment interaction (P = 
0.90), nor a day or treatment main effect (P = 0.35 and P = 0.61, respectively). Expression of 
GLUT3 in FM (data previously published; Crouse et al., 2016) was not influence by a day × 
treatment interaction (P = 0.33) and was greater (P = 0.04) on d 16 compared with d 50. 
Expression of GLUT5 was not influenced by a day × treatment interaction (P = 0.44), however 
was greater (P = 0.04) on d 16 (80.17-fold) compared with d 50 (27.39-fold; SEM = 13.8; Table 
4.4). Additionally, d 34 (45.11-fold) was intermediate and equal (P = 0.12) to both d 16 and 34 
(80.17 and 27.39-fold, respectively; SEM = 13.8; Table 4.4). Contrast statements for GLUT5 
revealed that days post-attachment was greater in expression than d pre-attachment (P = 0.01). 
Expression of GLUT14 (data previously published; Crouse et al., 2016) in FM was not influence 
by a day × treatment interaction, or main effects of day of gestation or treatment (P > 0.55). 
Arginine and lysine transporter CAT-1 was not influenced by a day × treatment interaction (P = 
0.99) and was greater (P < 0.01) on d 34 and 50 (0.23 and 0.19-fold) compared with d 16 (0.05-
fold; SEM = 0.03; Table 4.4). Expression of CAT-2 was not influenced by a day × treatment 
interaction (P = 0.47) and tended (P = 0.10) to be greater on d 34 (1.00-fold) compared with d 16 
of gestation (0.33-fold; SEM = 0.20; Table 4.4). Cationic amino acid transporter CAT-3 was not 
influenced by a day × treatment interaction (P = 0.52) nor a main effect of day or treatment (P = 
0.76 and P = 0.30, respectively; Table 4.4). 
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Table 4.5 Relative expression of glucose transporters GLUT1, GLUT3, and GLUT14 as well as fructose transporter GLUT5 across utero-
placental tissue type, day of gestation, and maternal nutritional treatment in relation to NP endometrium set to 1. 
  Day of Gestation1  Treatment2  P - values3 
Gene4 Tissue5 16 34 50 
Tissue 
Mean6 
CON RES SEM7 Tissue 
Trt  
× 
Tissue 
Day 
× 
Tissue 
GLUT1 
 
CAR 1.81a 0.51c 0.71c 1.01 0.98 1.04 0.26 < 0.01 0.36 < 0.01 
ICAR 1.72ab 0.93c 1.75ab 1.47 1.74 1.19 
  
  
 FM 0.17c 0.30c 0.30c 0.26 0.25 0.27 
  
  
            
GLUT3 CAR 1.57c 8.65ab 11.38a 7.20 9.19 5.21 1.93 0.01 0.31 0.02 
 ICAR 3.12c 2.05c 5.08bc 3.42 4.21 2.62     
 FM  4.39bc 2.64c 1.53c 2.85 2.44 3.26     
            
GLUT5 
 
CAR 4.35c 44.56a 5.31c 18.07 12.86 23.28 8.15 0.32 0.71 < 0.01 
ICAR    11.97c 17.20bc 16.58bc 15.28 17.38 13.12 
  
  
 FM    39.12ab 22.00bc 13.36c 24.83 24.29 25.38     
            
GLUT14 
 
CAR 1.21 2.24 4.31 2.59h 3.69 1.49 1.48 < 0.01 0.48 0.34 
ICAR 6.23 4.44 5.65 5.44g 6.05 4.83     
 FM 4.13 0.39 0.09 1.53h 1.04 2.03     
1Day of Gestation = number of days after insemination.  
2Treatment= Mean value of expression within tissue and treatment across all days of gestation.  CON = Heifers fed a diet that meets 100% 
of NRC requirements to gain 0.45 kg daily. RES =  Heifers restricted to 60% of CON diet 
3Probability values for effect of tissue, treatment × tissue and day × tissue on the mRNA expression of GLUT1, GLUT3, GLUT5, and 
GLUT14 in CAR, ICAR, and FM tissues.  
4Gene = GLUT1, GLUT3, and GLUT14- Glucose transporter solute carrier family 2 member 1, 3, and 14.GLUT5- Fructose transporter 
solute carrier family 2 member 5.  
5CAR- caruncles collected from the uterine horn ipsilateral to the corpus luteum. ICAR- intercaruncular endometrium collected from the 
uterine horn ipsilateral to the corpus luteum. FM- chorioallantois. 
6Mean expression within gene across day of gestation and nutritional treatment. 
7Average SEM for the day × tissue interaction was used.  
a-cMeans within gene without a common superscript differ in day × tissue (P ≤ 0.05). 
g-hMeans within  tissue mean column without a common superscript differ in main effect of tissue (P ≤ 0.05). 
1
0
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Day × Tissue and Tissue × Treatment.  
There was no treatment × tissue interaction for GLUT1, GLUT3, GLUT5, GLUT14, CAT-
1, CAT-2, or CAT-3 (P ≥ 0.25; Tables 4.5 and 4.6). Expression of GLUT1 was influenced by a 
day × tissue interaction being greater (P < 0.01) on d 16 in CAR (1.81-fold) intermediate on d 16 
and 50ICAR (1.72 and 1.75-fold) and greater (P ≤ 0.05) compared with d 16 FM (0.17-fold), d 
34 CAR, ICAR, and FM (0.51, 0.93, and 0.30-fold) and d 50 CAR and FM (0.71 and 0.30-fold; 
SEM = 0.26; Table 4.5). High capacity glucose transporter GLUT3 was influenced by a day × 
tissue interaction (P = 0.02), being greater on d 50 CAR (11.38-fold) than all other days and 
tissues except d 34 CAR (8.65-fold) which was intermediate and greater (P ≤ 0.05) than d 16 
CAR and ICAR (1.57 and 3.12-fold, respectively), d 34 ICAR and FM (2.05 and 2.64-fold, 
respectively), and d 50 FM (1.53-fold; SEM = 1.93; Table 4.5). Fructose transporter GLUT5 was 
influenced by a day × tissue interaction, being greater (P < 0.01) on d 34 in CAR (44.56-fold) 
than all other days and tissues except d 16 FM (39.12-fold) which was intermediate and greater 
(P ≤ 0.05) than d 16 CAR and ICAR (4.35 and 11.97-fold, respectively), d 34 ICAR and FM 
(17.20 and 22.00-fold, respectively), and d 50 CAR and FM (5.31 and 13.36-fold; SEM = 8.15; 
Table 4.5). Additionally, d 50 ICAR (16.58-fold) was equal (P ≥ 0.08) all days and tissues 
except d 34 CAR (44.56-fold; SEM = 8.15; Table 5). Duplicon GLUT14, was not influenced by 
a day × tissue interaction (P = 0.34) and was greater (P < 0.01) in ICAR (5.44-fold) compared 
with CAR and FM (2.59 and 1.53-fold; SEM = 0.86; Table 4.5). Cationic amino acid transporter 
CAT-1 was influenced by a day × tissue interaction (P < 0.01), being greater on d 34 ICAR 
(15.41-fold) than d 50 ICAR (11.72-fold) which was greater (P ≤ 0.05) than d 34 CAR (4.91-
fold), which was greater (P ≤ 0.05) than all other days and tissues (SEM = 1.08; Table 4.6). 
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Table 4.6 Relative expression of glucose transporters CAT-1, CAT-2, and CAT-3 across utero-placental tissue type, day of gestation, and 
maternal nutritional treatment in relation to NP endometrium set to 1. 
  Day of Gestation1  Treatment2  P - values3 
Gene4 Tissue5 16 34 50 
Tissue 
Mean6 
CON RES SEM7 Tissue 
Trt  
× 
Tissue 
Day 
× 
Tissue 
CAT-1 
 
CAR 1.39d 4.91c 0.48d 2.26 2.15 2.37 1.08 < 0.01 0.77 < 0.01 
ICAR 0.61d 15.41a 11.72b 9.25 8.85 9.91 
  
  
 FM 0.07d 0.37d 0.31d 0.25 0.2 0.26 
  
  
            
CAT-2 CAR 1.78 6.06 3.18 3.67h 3.85 3.50 0.93 < 0.01 0.57 0.08 
 ICAR 6.01 5.79 6.76 6.18g 6.96 5.42     
 FM 0.18 0.55 0.47 0.40i 0.42 0.38     
            
CAT-3 
 
CAR 1.30 1.63 3.11 2.01h 12.86 23.28 8.15 < 0.01 0.25 0.10 
ICAR    6.94 3.36 5.44 5.24g 17.38 13.12 
  
  
 FM    0.08 0.07 0.12 0.09i 24.29 25.38     
1Day of Gestation = number of days after insemination.  
2Treatment= Mean value of expression within tissue and treatment across all days of gestation.  CON = Heifers fed a diet that meets 100% 
of NRC requirements to gain 0.45 kg daily. RES =  Heifers restricted to 60% of CON diet 
3Probability values for effect of tissue, treatment × tissue and day × tissue on the mRNA expression of GLUT1, GLUT3, GLUT5, and 
GLUT14 in CAR, ICAR, and FM tissues.  
4Gene = CAT-1, CAT-2, and CAT-3 - Cationic amino acid transporters of arginine and lysine, solute carrier family 7 member 1, 2, and 3. 
5CAR- caruncles collected from the uterine horn ipsilateral to the corpus luteum. ICAR- intercaruncular endometrium collected from the 
uterine horn ipsilateral to the corpus luteum. FM- chorioallantois. 
6Mean expression within gene across day of gestation and nutritional treatment. 
7Average SEM for the day × tissue interaction was used.  
a-cMeans within gene without a common superscript differ in day × tissue (P ≤ 0.05). 
g-iMeans within  tissue mean column without a common superscript differ in main effect of tissue (P ≤ 0.05). 
1
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Expression of CAT-2 tended (P = 0.08) to be influenced by a day × tissue interaction and 
was greater (P < 0.01) in ICAR (6.18-fold) intermediate in (3.67-fold) and least in FM (0.40-
fold; SEM = 0.54; Table 4.6). Expression of CAT-3 tended (P = 0.10) to be influenced by a day × 
tissue interaction and was greater (P < 0.01) in ICAR (5.24-fold) intermediate in CAR (2.01-
fold) and least in FM (0.09-fold; SEM = 0.51; Table 4.6). 
Day 50 COT, ICOT, and AMN comparison.  
None of the nutrient transporters investigated were influenced by a tissue × treatment 
interaction, or a main effect of treatment (P > 0.05). Expression of GLUT1 was greater (P < 
0.01) in AMN (0.67-fold) compared with both COT and ICOT (0.24 and 0.29-fold; SEM = 0.07; 
Table 4.7). Expression of GLUT3 was greater (P < 0.01) in AMN (0.53-fold) compared with 
COT and ICOT (0.26 and 0.19-fold, respectively; SEM = 0.05; Table 4.7). Expression of GLUT5 
was greater (P < 0.01) in ICOT (30.49- fold) compared with AMN and COT (3.47 and 6.89-fold, 
respectively; SEM = 12.89; Table 7). Expression of GLUT14 was greater (P < 0.01) in AMN 
(4.48-fold) compared with both COT and ICOT (0.35 and 0.25-fold, respectively; SEM = 0.69; 
Table 7). Expression of CAT-1 was greater (P = 0.02) in AMN (0.30-fold) compared with COT 
and ICOT (0.22 and 0.17-fold; SEM = 0.03; Table 4.7). Expression of CAT-2 was greater (P = 
0.05) in AMN (3.27-fold) compared with ICOT (0.82-fold; SEM = 0.66; Table 7). Expression of 
CAT-3 was greater (P < 0.01) in AMN (7.64-fold) compared with both COT and ICOT (0.73 and 
2.75-fold; SEM = 1.38; Table 4.7). 
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Discussion 
These data are the first report on the impacts of maternal nutritional treatment and day of 
gestation on the mRNA expression of glucose and cationic amino acid transporters GLUT1, 
GLUT5, CAT-1, CAT-2, and CAT-3 in bovine utero-placental tissues from d 16 to 50 of 
gestation. The effect of maternal nutrition and day of gestation on expression of glucose 
transporters GLUT3 and GLUT14 reported within have been previously published by Crouse et 
al. (2016a) and are presented here (with permission) to provide a more complete representation 
of nutrient transporters during early pregnancy in beef heifers. As stated previously, we 
hypothesized that glucose transporter GLUT1, fructose transporter GLUT5, and cationic amino 
Table 4.7 Relative expression of nutrient transporters GLUT1, GLUT3, 
GLUT5, GLUT14, CAT-1, CAT-2, and CAT-3 in AMN, COT, and ICOT on 
d 50 of gestation using NP endometrium as a baseline value set to 1. 
Gene1 AMN2 COT3 ICOT4 SEM5 P-value6 
GLUT1 0.67a 0.24b 0.29b 0.07 < 0.01 
GLUT3 0.53a 0.26b 0.19b 0.05 < 0.01 
GLUT5 3.47b 6.89b 30.49a 12.89 < 0.01 
GLUT14 4.48a 0.35b 0.25b 0.69 < 0.01 
CAT-1 0.30a 0.22b 0.17b 0.03 0.02 
CAT-2 3.27a 1.42ab 0.82b 0.66 0.05 
CAT-3 7.64a 0.73b 2.75b 1.38 < 0.01 
1Gene = GLUT1- Glucose transporter solute carrier family 2 member 1. 
CAT-1, CAT-2, and CAT-3 - Cationic amino acid transporters of arginine 
and lysine, solute carrier family 7 member 1, 2, and 3. 
2Amnion collected on d 50 of gestation. 
3Cotyledons collected from fetal membranes on d 50 of gestation. 
4Intercotyledonary tissue (fetal membrane tissue not including cotyledons; 
collected from fetal membranes on d 50 of gestation). 
5Average SEM was used within gene; AMN n = 11, COT n = 14, ICOT n 
=14 
6Probability values for the effect of tissue on level of expression of 
individual genes. There was no significant tissue × treatment interaction or 
main effect of treatment, therefore they were omitted from the table. 
a-bMeans within gene without a common superscript differ by tissue (P ≤ 
0.05). 
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acid transporters CAT-1, CAT-2, and CAT-3 would be differentially expressed due to an 
interaction of day of gestation and maternal nutritional status. In keeping with our hypothesis, we 
determined that CAT-2 in ICAR was the only gene in any tissue to be influenced by a day × 
treatment interaction, and that the expression of glucose, fructose, and cationic amino acid 
transporters in the bovine utero-placenta are affected more so by day of gestation than a 40% 
global maternal nutritional restriction up to d 50 of gestation.  
Glucose transporter GLUT1 (SLC2A1) is a highly conserved glucose transporter which is 
found in high levels in all fetal tissues as well as being most abundant in fibroblasts, 
erythrocytes, and endothelial cells with low expression in muscle, liver, and adipose tissue in 
adults (Olson and Pessin, 1996). Glucose Transporter GLUT3 (SLC2A3) is the major neuronal 
glucose transporter, present in both dendrites and axons, and its level of expression in different 
regions of the brain correlates with regional cerebral glucose utilization (Simpson et al., 2008, 
Thorens and Mueckler, 2010). In mouse sperm, GLUT3 is highly expressed and controls glucose 
uptake and metabolism necessary for motility and maturation (Thorens and Mueckler, 
2010).  During embryonic development, GLUT3 is present in the trophectoderm at the blastocyst 
stage and, after implantation, in extra-embryonic tissues (Gao et al., 2009; Thorens and 
Mueckler, 2010). Although GLUT1 and GLUT3 are both high affinity glucose transporters, (~5 
mM and ~1.5mM respectively) GLUT3 transport capacity is the highest calculated of all the 
known GLUT isoforms, thus facilitating proportionally greater glucose uptake (Thorens and 
Mueckler, 2010). Fructose transporter GLUT5 (SLC2A5) is a facilitative diffusion fructose 
transporter (Corpe et al., 2002) known to be expressed in fast-cleaving embryos to enhance 
fructose uptake for nucleotide synthesis (Gutierrez-Adan et al., 2004; Forde et al., 2011). Most 
notably, GLUT5 is known for fructose transport in the small intestine, being located on the 
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apical membrane and facilitating transport of fructose from the lumen of the intestine into the 
enterocyte (Thorens, 2004). The glucose transporter gene GLUT14 (glucose transporter solute 
carrier family 2 member 14, also known as SLC2A14), encodes a protein that is 497 amino acids 
in length, and shares 95% homology to GLUT3 (Wu and Freeze, 2002). The GLUT14 gene is 
considered a duplicon, as it may have arisen as a possible result of a duplication of GLUT3 (Wu 
and Freeze, 2002). Contrary to GLUT3, however, GLUT14 has previously been observed as 
specifically expressed in the testis, and was found to have expression levels four-fold greater 
than GLUT3 in testis (Wu and Freeze, 2002), and only recently, has been isolated in bovine 
utero-placental tissues (Crouse et al., 2016a). 
Cationic amino acid transporters CAT-1, CAT-2, and CAT-3 (SLC7A1, SLC7A2, and 
SLC7A3) are part of the y+ system of transporters which are a facilitated diffusion sodium-
independent group of transporters known for transporting cationic amino acids such as arginine 
and lysine and at low pH, histidine (Closs et al., 2006). The three transporters studied vary in 
their stimulation and affinity; CAT-1 exhibits KM values for L-arginine, L-lysine of 100 to 150 
µM, and is strongly stimulated by substrate on the trans-side of the membrane (Kim et al., 1991; 
Closs et al., 1997); CAT-2 and CAT-3 exhibit lower substrate affinity and are less dependent on 
trans-stimulation (Closs et al., 1997; Vekony et al., 2001), with CAT-2 having about a tenfold 
lower substrate affinity compared with CAT-1 (Closs et al., 1993; Kavanaugh et al., 1994; Closs 
et al., 1997). Knockout of CAT-1 resulted in decreased arginine transport by 73%, and its 
catabolites, citrulline and ornithine, by 76% and 40% respectively, as well as decreased ornithine 
decarboxylase, NOS, and polyamines which resulted in retarded growth development of the 
conceptus (Wang et al., 2014). 
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 During the first 50 d of gestation, nutrition to the fetus from the maternal system are 
provided through secretions from the uterine glands collectively known as histotroph (Bazer et 
al., 2011). Histotroph, also known as uterine milk (Bonnet, 1882), is comprised of nutrient 
transport proteins, ions, mitogens, cytokines, lymphokines, enzymes, hormones, growth factors, 
proteases and protease inhibitors, amino acids, glucose, fructose, vitamins, and other substances 
(Bazer et al., 2011). Due to the absence of shared blood supply between the maternal and fetal 
systems during the first 50 days, it is hypothesized that amniotic fluid contains the nutrient 
reserve from which the conceptus draws to meet its energetic and growth requirements before the 
establishment of hemotrophic nutrition. Even during late gestation, the importance of transport of 
key nutrients into the amniotic fluid such as amino acids (glutamine and arginine), proteins, 
vitamins, minerals, hormones and growth factors become increasingly important in the fetal 
swallowing mechanism in amniotic fluid which prepares the gastrointestinal tract for postnatal 
nutrition (Underwood and Sherman, 2006). These data show that most all transporters 
investigated, with the exception of fructose transporter GLUT5, were more greatly expressed in 
AMN compared with COT and/or ICOT. The reported data further demonstrate the increased 
emphasis on the establishment of transporters in the amniotic sac to facilitate the transport of 
nutrients across the amniotic sac to provide sufficient nutrients for conceptus growth and 
utilization. The placenta serves as the site of conversion of glucose to fructose (Jinyoung et al., 
2012). The expression of GLUT5 on d 50 being greater in ICOT compared with COT and AMN 
supports this conversion, because as glucose is converted by the chorioallantois, increased 
transport of fructose into the allantoic fluid cavity would need to be facilitated by GLUT5 in 
order to transport fructose from the chorioallantois to the fetal fluids. 
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 Arginine/lysine co-transporter CAT-2 in ICAR was the only transporter in any tissue to 
be influenced by a day × treatment interaction. As previously stated, CAT-2 and CAT-3 have 
lower affinities for arginine and lysine compared with CAT-1, indicating preferential transport of 
arginine and lysine through CAT-1. These data shown with CAT-2 in ICAR, as well as the 
tendency of CAT-3 in ICAR to be influenced by a day × treatment interaction and CAT-3 in CAR 
tending to be greater in CON compared with RES heifers may support the theory that at certain 
time points and nutritional treatments, the amount of arginine and lysine to be transported to the 
developing conceptus exceeds the transport capacity of CAT-1, therefore stimulating the 
expression of CAT-2 and CAT-3 as seen in these tissues to increase transporter number and 
transport capacity to the fetus. The other transporters investigated within, GLUT1, GLUT3, 
GLUT5, and CAT-1 are all high capacity high affinity glucose, fructose, or arginine/lysine 
transporters, and due to their transport capabilities, may be less likely to be affected in 
expression due to nutritional treatment. 
Previous data from Crouse et al. (2016b) evaluating the mRNA expression of glucose 
transporters GLUT1 and GLUT3 as well as cationic amino acid transporters SLC7A1, SLC7A2, 
and SLC7A3 (CAT-1, CAT-2, and CAT-3) on d 16, 22, 28, 34, 40, and 50 of gestation in CAR, 
ICAR, and FM found similar results across day of gestation as reported here.  
Expression of GLUT1 in CAR was greater on d 16 of gestation, in the current study, as 
well as Crouse et al. (2016b). Additionally, these results present a similar time frame of 
expression in bovine as they do in ovine, in which GLUT1 was greater in expression in 
endometrial tissue from d 10 to 16 of gestation reaching a peak level of expression on d 14 of 
gestation (~d 16-17 in bovine; Sanger, 2012; Gao et al., 2009a) and decreasing to d 20 (~ d 22 in 
bovine). Interestingly, expression of GLUT5 was greater on d 34 in CAR, which corresponds to 
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the time of completed adhesion and differentiation of the chorioallantois into the cotyledonary 
and intercotyledonary placenta. These data are very interesting due to the low concentration of 
fructose in the maternal serum during this time frame (0.80 mM; data not shown), as well as the 
low level of expression of the cotyledon (site of attachment to the caruncle forming the 
placentome) compared with the intercotyledonary placenta seen on d 50. Fructose transporter 
GLUT5, in addition to transporting fructose, also transports glucose, however has a lower 
affinity for glucose compared with fructose (Kayano, et al., 1990). The increased expression of 
GLUT5 may be partially explained by an increased necessity of glucose during this time point in 
gestation. Similar results across year were found in CAT-1, which was greater in expression on d 
28, 34, and 40 of gestation (Crouse et al., 2016b), as well as greater in CAR on d 34 compared 
with d 16 and 50 in the current study. Arginine/lysine cotransporter CAT-2 and CAT-3 were 
expressed differently across day from this study compared with the previous study (Crouse et al., 
2016b). In the previous study, CAT-2 showed no effect of day of gestation in CAR, and CAT-3 
was greater on d 16 and returned to levels similar to NP by d 22 through 50 of gestation. These 
data may once again be explained by the theory of maximizing transport capacity of CAT-1 
thereby increasing transport of arginine and lysine mediated through CAT-2 and CAT-3 during 
critical time points in gestation. Another hypothesis may be that the diets from this study 
compared with the previous were greater in energy and protein content per unit dry matter. 
Crouse et al. (2016b) targeted gains of 0.3 kg/heifer/d whereas the CON diet in the current study 
targeted 0.45kg/heifer/d with the RES heifers targeted to maintain weight. Additionally, 
composition of the diets differed, in which the current heifers were supplemented with DDGS 
increasing the availability of arginine and lysine to be transported to the conceptus, therefore 
increasing the need of additional cationic amino acid transporters. 
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The intercaruncular tissue of the uterus is the glandular tissue which transports histotroph 
into the uterine lumen for use by the conceptus (Bazer et al., 2012). Glucose transporter GLUT1 
showed similar patterns of expression in ICAR as in CAR, being greater on d 16 of gestation, 
which is also expression seen in previous studies by Crouse et al., (2016). The expression of 
CAT-1 in ICAR being greater in pregnant heifers across all days of gestation compared with non-
pregnant heifers on d 16 of the luteal cycle indicated the importance of arginine transport into the 
uterine lumen to be used by the developing conceptus. Arginine, coupled with secreted 
phosphoprotein1 within the uterine lumen, stimulated the growth, migration, cytoskeletal 
remodeling, and adhesion of the trophectoderm (Bazer et al., 2011), indicating the high degree of 
importance of arginine from the glandular epithelium of the uterus as supported by our results. 
Expression of GLUT5 in FM supports previous research from Gutierrez-Adan (2004), in 
which GLUT5 is established on the fast-cleaving bovine embryo to enhance nucleotide 
synthesis. Expression decreased from 80-fold greater than NP on d 16 to 27-fold greater than NP 
by d 50. In addition to the embryo hatching, prior to the establishment of hemotrophic nutrition 
and gas exchange, the uterus is a hypoxic environment, and it is in this environment in which 
fructose is more readily used compared with glucose (Jinyoung et al., 2012). As vascularization 
and development of the chorioallantois increases, expression of GLUT5 decreases, signaling a 
potential shift in utilization of fructose and glucose. This data is supported by Greseth et al., 
(2016) in which concentrations of fructose decrease from d 40 to 50 in amniotic fluid (3.43 to 
2.06mM, respectively). Simultaneously, glucose concentration on d 40 and 50 increased in 
amniotic fluid (1.46 to 1.68 mM, respectively; M. S. Crouse et al., unpublished data).  
When comparing GLUT1 across tissue and day of gestation, expression patterns indicated 
that GLUT1 may be the main pre-attachment glucose transporter in order to ensure sufficient 
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hexose availability to the developing conceptus. Additionally, I hypothesize that GLUT3 would 
be the main glucose transporter to be established on the placentome due to increased expression 
levels of GLUT3 on the caruncle by d 50 of gestation compared with all other tissues and days. 
Independent analysis of GLUT3 expression between COT and ICOT on d 50 determined that 
GLUT3 tended (P = 0.10; data not shown) to be greater in COT compared with ICOT, indicating 
that in fact, GLUT3 may be the main high capacity glucose transporter to be established on the 
site of the placentome as gestation progresses. Confirmation of these would need to be obtained 
by localizing GLUT3 to the placentome and measuring the abundance of GLUT3 in comparison 
to uterine glands, or inter-cotyledonary placenta. The expression patterns of GLUT5 between 
tissues are incredibly interesting. Although concentrations of fructose in maternal serum are 
nearly 4 to 10-fold lower than what is seen in fetal fluids, expression of GLUT5 in d 34 CAR is 
equal to that of d 16 FM. Current literature reviewed does not provide an answer to this, as it 
would be expected to see a greater expression of GLUT5 in FM compared with both CAR and 
ICAR simply on the grounds of fructose concentrations in fetal fluids being greater than that of 
maternal serum, and site of conversion of glucose to fructose within the chorioallantois 
(Jinyoung et al., 2012). Although transport capacity of GLUT14 has yet to be established, the 
expression of GLUT14 being greater in ICAR across all days of gestation may be beneficial for 
the conceptus in terms of localization of a known high capacity transporter on the placentome 
(GLUT3), and a potential high capacity transporter in the glandular tissue of the uterus 
(GLUT14).  
Expression of all three cationic amino acid transporters may indicate a specific transport 
of arginine by the glandular tissue of the uterus into the uterine lumen. All genes investigated 
were greater in ICAR, intermediate in CAR, and least in FM, suggesting the increased 
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prevalence of arginine transport into the uterine lumen compared with across the developing 
placentome or chorioallantois. Arginine is a major component of histotroph, and along with 
secreted phosphoprotein1 (SPP1), promotes cellular proliferation, migration, adhesion, 
differentiation, and survival (Wang et al., 2016). The combination of arginine and SPP1 causes 
the conformational change and cytoskeletal remodeling of the spherical blastocyst to the 
elongated, tubular and filamentous form before adhesion (d 12-17 of gestation) through the 
stimulus of mammalian target of rapamycin complex 2 (mTORC2; Wang et al., 2016). Although 
not previously determined, may be possible that additional arginine is to be transported into the 
uterine lumen around d 34 of gestation, which coincides with completion of attachment and the 
beginning of differentiation of the cotyledonary and intercotyledonary placenta. This additional 
arginine may be necessary for activation of mTORC2, which we hypothesize may be involved in 
the cytoskeletal restructuring of the chorioallantois into the cotyledonary tissue of the placenta. 
Although previous research by Crouse et al. (2016) and Wu et al., (2004) has shown that 
concentrations of arginine in the fetal fluids of the bovine and ovine are nearly 3 to 6 times 
greater than what is found in maternal serum, it is interesting to find that the mRNA expression 
of fetal tissues is lower than endometrial tissues. Therefore, analysis of concentrations of 
nutrients in maternal serum, histotroph, allantoic, and amniotic fluids would further delineate the 
effects of restricted maternal intake on whole nutrient transporter function and flux of nutrients 
from the maternal to the fetal system. 
 
Conclusion 
In conclusion these data emphasize that nutrient transporters in bovine utero-placental 
tissues are influenced more so by day of gestation, than a 40% global nutrient restriction. 
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Additional data evaluating concentrations of glucose, fructose, and cationic amino acids in utero-
placental tissues should be conducted to determine how a 40% global nutrient restriction affects 
flux of nutrients to the developing conceptus. Additionally, high concentrations of non-essential 
amino acids such as glycine, glutamine, and serine have been reported in fetal fluids (Kwon et 
al., 2003). Investigating the effects of maternal nutritional status on neutral amino acid 
transporter expression and neutral amino acid flux to the conceptus may provide further insight 
into the effects of nutrient restriction of the dam on conceptus development. 
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CHAPTER 5: GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
General Discussion and Speculation 
 The results of this thesis have demonstrated that there is an effect of day of gestation on 
the mRNA expression of glucose and cationic amino acid transporters in bovine utero-placental 
tissues from days 16 to 50 of gestation. It has also been established that glucose and arginine 
concentrations in maternal and fetal fluids are affected by day of gestation. Only one gene 
transcript, CAT-2, was influenced by a day × treatment interaction, and one gene, CAT-3, tended 
to be influenced by maternal nutritional treatment. We interpret these results to imply that day of 
gestation, more so than maternal nutritional status, affect the expression of glucose and cationic 
amino acid transporters in bovine utero-placental tissues from days 16 to 50 of gestation.  
 Additionally, these data are the first to elucidate expression of GLUT14 in bovine utero-
placental tissues, as well as confirm the presence of GLUT3 in these tissues. Glucose transporter 
GLUT3 has the highest known transport capacity of any glucose transporter in the mammalian 
body. Therefore, establishment of GLUT3 as well as its duplicon, GLUT14 in bovine utero-
placental tissues supports previous data highlighting the necessity of glucose flux to the 
developing fetus.  
Although GLUT1 and GLUT3 are both high affinity glucose transporters, (~5 mM and 
~1.5mM respectively) GLUT3 transport capacity is the highest calculated of all the known 
GLUT isoforms, thus facilitating proportionally greater glucose uptake (Thorens and Mueckler, 
2010). Increased expression of GLUT3 as gestation progresses (as seen in caruncular tissue 
increasing to d 50) may indicate the preferential utilization of a high capacity glucose transporter 
as energetic demands of the conceptus increase in order to ensure the success of pregnancy and 
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adequate development. This rationale is also supported by Ganguly et al. (2007) who reported 
that a null mutation of GLUT3 resulted in early embryonic mortality in mice due to increased 
apoptosis in blastocysts. Data from Crouse et al., (2016) in bovine chorioallantois, found that 
GLUT3 expression was greater in pre-implantation fetal membranes compared with post-
implantation fetal membranes. Additionally, GLUT3 null mice failed to survive post 
implantation, even in nutrient rich growth mediums, due to failed neurulation (d ~ 8.5; Total 
gestation ~ 20 d), or late-gestation fetal growth restriction characterized by decreased GLUT3- 
mediated transplacental glucose transport (Ganguly et al., 2007). Thus suggesting that bovine 
utero-placental tissues preferentially utilize GLUT3 over GLUT1 as the growth curve and energy 
demands of the conceptus increase in order to provide sufficient glucose to prevent early 
embryonic mortality.  In addition, the greater expression of GLUT3 on d 50 in CAR, as well as 
greater still on d 34 in CAR compared with ICAR on all days of gestation provides insight into 
the prevalence of GLUT3 within the developing placentome. Histological results from our 
laboratory localized GLUT3 in bovine utero-placental tissues, with specific localization in the 
caruncle on d 50 of gestation (Osei et al., 2016). Although not collected or measured, it would be 
of significant interest in future studies to evaluate the presence and level of expression of GLUT3 
in cotyledon and inter-cotyledonary tissue to determine if the presence and expression of GLUT3 
in fetal tissues follow patterns similar to maternal tissue.   
In all three cationic amino acid transporters investigated (SLC7A1, SLC7A2, and 
SLC7A3), greater levels of mRNA expression were observed during key days of gestation; d 16 
at maternal recognition of pregnancy and implantation, and d 28 to 40 the critical window of 
placental development beyond which little embryonic/fetal loss occurs (Thatcher et al.,1994; 
Bridges et al., 2013). In FM, SLC7A1 peaked in expression on d 34 and 50, coinciding with 
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increased expression on d 34 in maternal tissues. Concentration of arginine was greater on d 40 
compared with d 50 of gestation, following a similar pattern as seen in maternal and fetal 
transporter expression, being greater d 34 of gestation and decreasing to d 50. This pattern of 
expression coinciding with arginine abundance may indicate the increased abundance of 
SLC7A1 to be established in the endometrium and chorioallantois in order to transport greater 
quantities of arginine to the fetus.  
Supplemental lysine in the diet of rats reduced proteolysis and autophagy as well as 
upregulating the mTOR signaling pathway (Sato et al., 2015). Additional information regarding 
the significance of lysine in fetal mTOR pathways was not found in ruminants; however, mean 
concentrations of lysine, were greater than that of arginine in our heifers. This observation 
indicates that lysine may potentially play a great role in stimulating protein synthesis and 
differentiation during the first 50 days of gestation compared with arginine. An additional 
hypothesis to explain the difference between arginine and lysine would be the catabolism of 
arginine to its catabolites ornithine and citrulline, thus decreasing the concentration of arginine in 
fetal fluids compared with lysine. Because lysine uses the same intracellular transporter system 
as arginine, competition of transport can be hypothesized (Luiking and Deutz, 2007) and 
subsequently there is equal probability of arginine or lysine to be transported by any one 
individual transporter which in theory could make total concentrations of arginine and lysine 
transported equal. Interestingly, when the concentration of arginine, citrulline, and ornithine are 
added together and compared to lysine in allantoic fluid (579.33 vs. 634.50 µmol/L, 
respectively), we find that concentrations of arginine and lysine are more equal than the raw 
means of arginine vs. lysine individually. Additionally, we see similar patterns in amniotic fluid 
in which arginine and ornithine together are numerically greater compared with lysine 
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concentrations (244.66 vs. 236.95, respectively). These data may support the hypothesis that 
arginine is being metabolized within the allantoic and amniotic fluid to ornithine and citrulline in 
order to increase the abundance of polyamines and NO. Enzymatic analysis of arginase, nitric 
oxide synthase, and ornithine transcarbamoylase would provide increased information to answer 
this question and would be of interest to future studies. 
Genes were greater in mean expression across all days in either CAR (GLUT3 and 
SLC7A3), ICAR (SLC7A1), or both CAR and ICAR (GLUT1 and SLC7A2) compared with FM 
during the first 50 days of gestation. Although there was a general numerical increase in the 
expression of all transporters in FM; the overall expression of these transporters were never 
greater than the expression seen in either CAR or ICAR. These data align with findings of Gao et 
al. (2009 a, b) emphasizing the importance of nutrient transport into the uterine lumen during the 
period of placental differentiation. Investigating placental transporter expression past d 50 of 
gestation may deduce the time change in which placental transport exceeds that of uterine 
transport of nutrients. Alternatively, this time may never be reached indicating that at the time of 
establishment of hemotrophic nutrition, most efficient transport of nutrients is through the shared 
maternal/fetal blood supply. Additionally comparison of nutrient composition of histotroph to 
that of allantoic and amniotic fluids would provide greater insight into the transport capacity of 
placental transporters during the first 50 days of gestation. 
 Any project is not without areas of improvement. Beginning with chapter two, which was 
a preliminary study. A more complete study would have had tissues collected on every day of 
gestation from day 16 to 50 in order to better determine key dates for study for chapters three and 
four. However, this would have required nearly six times more animals to complete the study, 
and an even greater amount of time and man power. Due to constraints in time, manpower, and 
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funding, this was not possible; therefore, the dates chosen reflect key dates of gestation with 
minimal spacing between dates of surgery. The studies conducted for chapters two and three also 
could have been improved with a more consistent feeding approach. These heifers were switched 
between diets during the middle of the study due to lack of fermented feed. The diet switch for 
these heifers may have influenced specific nutrient flux to the conceptus, although the diets 
(haylage and silage) were fed to the same protein and energy requirements. Additionally, the 
duration of nutritional treatment in chapter 3 and 4 may not have been long enough to impact 
gene expression in these heifers. Finally, one of the last areas of criticism would be the idea of 
global nutrient restriction. Although in theory, when animals are not being fed adequately in the 
dry lot, pasture, or feedlot, the whole diet would be globally restricted. However, interpretation 
of results becomes more difficult, as we are unable to tell with certainty, which nutrient(s) were 
causing the changes expression and or nutrient concentrations. Limiting single nutrients at a time 
would more clearly begin to delineate which nutrients are in fact vital to conceptus growth and 
development during this stage of gestation, bringing us closer to a feeding strategy which can be 
implemented in a production setting in an effort to decrease spontaneous abortions during early 
gestation.  
 
Future Directions 
 The project itself had several ways in which it could have been improved upon; however, 
the data elucidated has opened more doors for future research. The obvious being to conduct the 
study with more controlled feeding parameters, and a more selective nutrient deficiency to better 
elucidate the mechanisms occurring during this timeframe. Additionally, completing the amino 
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acid profile and including neutral and anionic amino acids would provide a more complete 
picture of fetal energetic demands. 
 On a braoder scale, which reaches beyond the scope of the current project, we have 
determined that expression of nutrient transporters, and nutrient concentrations in fetal fluids are 
affected by day of gestation. Therefore, it is understandable that a perturbation in flux of 
nutrients during critical time points in gestation can have detrimental effects on the growth and 
development of the fetus throughout gestation and postnatally as well. With this in mind, future 
projects could investigate timing of nutrient restriction during pregnancy on “programming” of 
detrimental outcomes (metabolic syndrome, growth defects, and mortality) which become 
imprinted into the genome. Determining whether nutritional perturbations to the fetus during 
specific time points would imprint susceptibilities to chronic diseases would provide greater 
information into how nutritional timing during gestation affects fetal growth and development. 
With this data we could more specifically isolate time points in gestation which will be affecting 
growth and development of certain organ systems to more effectively mitigate these effects and 
more successfully raise beef cattle to feed the growing population of the world. 
